Podcasts about rescheduling

  • 324PODCASTS
  • 457EPISODES
  • 39mAVG DURATION
  • 5WEEKLY NEW EPISODES
  • Sep 30, 2025LATEST

POPULARITY

20172018201920202021202220232024


Best podcasts about rescheduling

Latest podcast episodes about rescheduling

Psychedelics Today
PT 627 - Mary Carreon — Censorship, Psychedelic Media & Policy Crosscurrents

Psychedelics Today

Play Episode Listen Later Sep 30, 2025 71:31


Episode summary Joe and Mary dive into how platform censorship and shifting algorithms have reshaped psychedelic media, why DoubleBlind moved to a “newsletter-first” model, and what that's revealed about true audience engagement. They reflect on the post-2024 MDMA decision headwinds, state-level policy moves (wins and losses), and how funding, politics, and culture continue to reconfigure the field. They also explore alternatives to alcohol, chronic pain research, reciprocity around iboga/ibogaine, and lessons from PS25 (MAPS' Psychedelic Science 2025). Highlights & themes From platforms to inboxes: Social and search suppression (IG/FB/Google) throttled harm-reduction journalism; DoubleBlind's pivot to email dramatically improved reach and engagement. Post-MDMA decision reality: Investment cooled; Mary frames it as painful but necessary growth—an ecosystem “airing out” rather than a catastrophic pop. Policy pulse: Mixed year—some state measures stalled (e.g., MA), others advanced (e.g., NM; ongoing Colorado process). Rescheduling cannabis may add complexity more than clarity. Censorship paradox: Suppressing education makes use less safe; independent outlets need community support to keep harm-reduction info visible. Chronic pain & long COVID: Emerging overlaps and training efforts (e.g., Psychedelics & Pain communities) point beyond a psychiatry-only frame. Alcohol alternatives: Low-dose or occasional psychedelic use can shift habits for some; Mary stresses individual context and support beyond any single substance. Reciprocity & iboga: Rising interest (including from right-leaning funders) must include Indigenous consultation and fair benefit-sharing; pace of capitalism vs. community care is an active tension. PS25 field notes: Smaller, more manageable vibe than 2023; fewer “gold-rush” expectations; in-person dialogue beats online flame wars. Notable mentions DoubleBlind: Newsletter-first publishing; nurturing new writers and reported stories. Psychedelics & Pain Association / Clusterbusters: Community-driven models informing care and research (cluster headache protocols history). Books & media: Body Autonomy (Synergetic Press anthology); Joanna Kempner's work on cluster headaches - Psychedelic Outlaws; Lucy Walker's forthcoming iboga film. Compounds to watch: LSD (under-studied relative to MDMA), 2C-B, 5-MeO-DMT (synthetic focus), and broader Shulgin-inspired families.   Mary Carreon: [00:00:00] Okay, I'm gonna send it to my dad because he wants to know. Here Joe Moore: we go. Yeah, send it over. So, hi everybody. We're live Joe here with Mary Anne, how you doing today? Mary Carreon: I'm great Joe. How are you? Joe Moore: Lovely. I actually never asked you how to pronounce your last name does say it right? Mary Carreon: Yes, you did. You said it perfectly Joe Moore: lovely. Joe Moore: Um, great. So it's been a bit, um, we are streaming on LinkedIn, YouTube, Twitch X and Kick, I guess. Yeah. Kick meta. Meta doesn't let me play anymore. Um, Mary Carreon: you're in forever. Timeout. I got it. I got it. Yeah. Joe Moore: Yeah. I think they found a post the other day from 2017. They didn't like, I'm like, oh cool. Like neat, you Mary Carreon: know, you know. Mary Carreon: Yeah. That happened to me recently, actually. Uh, I had a post taken down from 2018 about, uh, mushroom gummies and yeah, it was taken down and I have strikes on my account now. So Joe Moore: Do you get the thing where they ask you if you're okay? Mary Carreon: Yes, with, but like with my searches though, [00:01:00] like if I search something or, or someone's account that has, uh, like mushroom or psychedelic or LSD or something in it, they'll be like, mm-hmm are you okay? Mary Carreon: And then it recommends getting help. So Joe Moore: it's like, to be fair, I don't know if I'm okay, but Yeah, you're like, probably not. I don't really want your help. Meta. Yeah. Mary Carreon: You're like, I actually do need help, but not from you. Thanks. Yeah, Joe Moore: yeah, yeah. Mary Carreon: So not from the techno fascists. Joe Moore: Oh, good lord. Yeah. Uh, we'll go there. Joe Moore: I'm sure. Mary Carreon: I know. I just like really dove right there. Sorry. Yeah. All right, so let's, Joe Moore: um, before we go, let's give people like a bit of, you know, high kicks on, on who is Mary, where you working these days and what are you doing? Mary Carreon: Yeah, thank you. My name is Mary Carryon and I am forever and first and foremost a journalist. Mary Carreon: I have been covering, I say the plant legalization spaces for the past decade. It's, it's been nine and a half years. Uh, on January 3rd it will be [00:02:00] 10 years. And I got my start covering cannabis, uh, at OC Weekly. And from there went to High Times, and from there went to Mary Jane, worked for Snoop Dogg. And then, uh, I am now. Mary Carreon: Double blind. And I have become recently, as of this year, the editor in chief of Double Blind, and that's where I have been currently sinking my teeth into everything. So currently, you know, at this moment I'm an editor and I am basically also a curator. So, and, and somebody who is a, uh, I guess an observer of this space more than anything these days. Mary Carreon: Um, I'm not really reporting in the same way that I was. Um, but still I am helping many journalists tell stories and, uh, I feel kind of like a story midwife in many ways. Just like helping people produce stories and get the, get the quotes, get the angles that need to be discussed, get the sentences structures right, and, um, uh, helping [00:03:00] sometimes in a visionary kind of, uh, mindset. Mary Carreon: So yeah, that's what I'm doing these days. Joe Moore: Oh, there it is. Oh, there you are. Love that. And um, you know, it's important to have, um, editors who kind of really get it from a lot of different angles. I love that we have a lot of alignment on this kind of, and the drug war thing and kind of let's, uh, hopefully start developing systems that are for people. Joe Moore: Yeah, absolutely. If you wanna just say that. Yeah, absolutely. Mary Carreon: Yeah, absolutely. Joe Moore: So, um, yeah, I almost 10 years in January. That's great. We um, it's so crazy that it's been that long. I think we just turned nine and a half, so we're maybe just a few, a few months shorter than your I love it. Plant medicine reporting career. Joe Moore: That's great. I love it. Um, yeah, so I think. I think one of the first times we chatted, [00:04:00] um, I think you were doing a piece about two cb Do you, do you have any recollection of doing a piece on two cb? Mary Carreon: I do, yes. Yes. Wait, I also remember hitting you up during an Instagram live and I was like, are you guys taking any writers? Mary Carreon: And you guys were like writers, I mean, maybe depending on the writer. Joe Moore: And I was like, I was like, I dunno how that works. Mary Carreon: Like me. Yeah. Joe Moore: Yeah. It was fun. It was fun to work with people like yourself and like get pieces out there. And eventually we had an awesome editor for a bit and that was, that was really cool to be able to like support young startup writers who have a lot of opinions and a lot of things to point out. Joe Moore: There's so much happening. Um, there was so much fraud in like wave one. Of kind of the psychedelic investment hype. There's still some, but it's lesser. Um, and it's really a fascinating space still. Like changing lives, changing not just lives, right? Like our [00:05:00] perspective towards nearly everything, right? Joe Moore: Yeah. Mary Carreon: Yes, absolutely. Absolutely. I mean, it's interesting because the space has matured. It's evolved. It's different than it was even, what a, I mean, definitely nine years ago, but even five years ago, even four years ago, even last year, things are different. The landscape is different than it was a year ago. Mary Carreon: And I, it's, it's interesting to see the politics of things. It's interesting to see who has money these days given like how hard it is just to kind of survive in this space. And it's interesting just to. Bear witness to all of this going down because it really is a once in a lifetime thing. Nothing is gonna look the same as it does now, as it, uh, then it will like in a, in a year from now or anything. Mary Carreon: So it's really, yeah. It's interesting to take account of all of this Joe Moore: That's so real. Uh, maybe a little [00:06:00] too real, like it's serious because like with everything that's going on from, um, you know, governance, governments, ai Yes. Drug policy shifts. Drug tech shifts, yes. There's so much interesting movement. Um, yes. Joe Moore: You, you know, you, you kind of called it out and I think it's really actually worth discussing here since we're both here on the air together, like this idea that the psychedelic market, not idea, the lived experience of the psychedelic market having shifted substantially. And I, I, I think there's a lot of causes. Joe Moore: But I've never had the opportunity to really chat with you about this kind of like interesting downturn in money flowing into the space. Mm-hmm. Have you thought about it? Like what might the causes be? I'm sure you have. Mary Carreon: Yeah. Yeah, I have. Yeah. I've thought about it. I mean, it's hard. Well, I don't know. I am really not trying to point fingers and that's not what I'm [00:07:00] trying to do here. Mary Carreon: But I mean, I think a lot of people were really hopeful that the FDA decision last June, not last June, the previous June, a year ago, 2024, June was going to open the floodgates in terms of funding, in terms of, um. In terms of mostly funding, but also just greater opportunities for the space and, uh, greater legitimacy granted to the psychedelic medicine space. Mary Carreon: Mm. And for those who might not know what I'm talking about, I'm talking about the, uh, FDA decision to reject, uh, MDMA assisted therapy and, um, that whole, that whole thing that happened, I'm sure if it, you didn't even have to really understand what was going on in order to get wind of that wild situation. Mary Carreon: Um, so, so maybe, yeah. You probably know what I'm talking about, but I, I do think that that had a great impact on this space. Do I think it was detrimental to this space? [00:08:00] I don't think so. We are in a growth spurt, you know, like we are growing and growing pains happen when you are evolving and changing and learning and figuring out the way forward. Mary Carreon: So I think it was kind of a natural process for all of this and. If things had gone forward like while, yeah, there probably would be more money, there would be greater opportunity in this space for people wanting to get in and get jobs and make a living and have a life for themselves in this, in this world. Mary Carreon: I don't know if it was, I don't know if it would necessarily be for the betterment of the space in general for the long term. I think that we do have to go through challenges in order for the best case scenarios to play out in the future, even though that's difficult to say now because so many of us are struggling. Mary Carreon: So, but I, but I have hope and, and that statement is coming from a place of hope for the future of this space and this culture. Joe Moore: Yeah. It's, um, I'm with [00:09:00] you. Like we have to see boom bust cycles. We have to see growth and contraction just like natural ecosystems do. Mary Carreon: Absolutely, absolutely. It has to be that way. Mary Carreon: And if it's not that way, then ifs, if. It's, it like what forms in place of that is a big bubble or like a, a hot air balloon that's inevitably going to pop, which, like, we are kind of experiencing that. But I think that the, I think that the, um, the, the air letting out of the balloon right now is a much softer experience than it would be if everything was just like a green light all the way forward, if that makes sense. Mary Carreon: So, Joe Moore: right. And there's, there's so many factors. Like I'm, I'm thinking about, uh, metas censorship like we were talking about before. Yes. Other big tech censorship, right? Mm-hmm. SEO shifts. Mary Carreon: Oh. Um, yes, absolutely. Also, uh, there were some pretty major initiatives on the state level that did not pass also this past year that really would've also kind of [00:10:00] helped the landscape a little bit. Mary Carreon: Um. In terms of creating jobs, in terms of creating opportunities for funding, in terms of having more, uh, like the perception of safer money flow into the space and that, you know, those, those things didn't happen. For instance, the measure for in Massachusetts that didn't go through and just, you know, other things that didn't happen. Mary Carreon: However, there have been really good things too, in terms of, uh, legalization or various forms of legalization, and that's in New Mexico, so we can't, you know, forget that there, and we also can't forget just the movement happening in Colorado. So there are really great things happening and the, the movement is still moving forward. Mary Carreon: Everything is still going. It's just a little more difficult than maybe it could have been Joe Moore: right. Yeah. Amen. Amen. Yes. But also, we Mary Carreon: can't forget this censorship thing. The censorship thing is a horse shit. Sorry. I'm not sure if I'm allowed to cuss, but it is, [00:11:00] but it is Joe Moore: calling it out and it's important to say this stuff. Joe Moore: And you know, folks, if you want to support independent media, please consider supporting Doubleblind and psychedelics today. From a media perspective, absolutely. We wanna wanna put as much out as we can. Yes. The more supporters we have, the more we can help all of you understand what's happening and yes. Joe Moore: Getting you to stay safer. Mary Carreon: Yeah, absolutely. And that's the whole difficulty with the censorship is that psychedelics today, and Doubleblind for instance, but also Lucid News, also other, uh, other influencers, other creators in the space, they like. What all of us are doing is putting out information that is ultimately creating a safer user experience. Mary Carreon: And so with the censorship, we are not able to do so anymore, which creates actually a lot of danger. So. Yeah, it's, it's difficult. The censorship is difficult, and if you are somebody who posts about psychedelics, I know that you know this and I am preaching to the choir. Joe Moore: Yeah. So can you talk a [00:12:00] little bit about you all at Double Blind made a major shift in the last number of months towards, uh, kind of not necessarily putting everything out there and, and kind of like, um, actually I don't even know the language you use. Joe Moore: What's the, what's the language you use for the kind of model shift you took on? Mary Carreon: Yeah, I mean, it's great. It's been a wild shift. It's been a wild shift. Um, what we are currently doing is we went to a newsletter first model, which instead of just posting onto a website for everyone to see, and then, um, you know, hopefully getting SEO hits and also posting on their, then posting those stories onto Instagram and Facebook and Twitter, and hoping to get traffic through social media. Mary Carreon: Uh, we decided that that was no longer working for us because it wasn't, um, because the censorship is so bad on, on social media, like on Instagram, for instance, and Facebook and Twitter, well, less on Twitter, [00:13:00] but still, nonetheless on social media, the censorship is so bad. And also the censorship exists on Google. Mary Carreon: When you Google search how to take mushrooms, double blinds is not even on. You know, our guide is not on the first page. It's like, you know, way the heck, way the heck down there. Maybe page 2, 3, 4, 5. I don't know. But, um, the issue, the issue with that, or, or the reason why rather that it's that way is because Google is prioritizing, um, like rehabilitation centers for this information. Mary Carreon: And also they are prioritizing, uh, medical information. So, like WebMD for instance. And all of these organizations that Google is now prioritizing are u are, are, are, are organizations that see psychedelic use through the lens of addiction or through drug drug abuse. So [00:14:00] again, you know, I don't know, take it for how you want to, I'm not gonna say, I'm not gonna tell anybody like what is the right way to use their substances or whatever. Mary Carreon: However, it's really important to have the proper harm reduction resources and tools available. Uh, just readily available, not five pages down on a Google search. So anyways, all of that said double blind was our traffic was way down. And it was looking very bleak for a while. Just we were getting kicked off of Instagram. Mary Carreon: We weren't getting any traffic from social media onto our website, onto our stories. It was a, it was a vicious kind of cycle downward, and it wasn't really working. And there was a moment there where Doubleblind almost shut down as a result of these numbers because there's a, like you, a media company cannot sustain itself on really low page views as a result. Mary Carreon: So what we [00:15:00] decided to do was go to a newsletter first model, which relies on our email list. And basically we are sending out newsletters three days a week of new original content, mostly, uh, sometimes on Wednesdays we repost an SEO story or something like that. Um, to just to engage our audience and to work with our audience that way, and to like to actually engage our audience. Mary Carreon: I cannot emphasize that enough because on Instagram and on Facebook, we were only reaching like, I don't know, not that many people, like not that many people at all. And all of that really became obvious as soon as we started sending out to our email list. And as soon as we did that, it was wild. How many, how many views to the website and also how many just open like our open rate and our click through rate were showing how our audience was reacting to our content. Mary Carreon: In other words. [00:16:00] Social media was not a good, in, like, was not a good indicator of how our content was being received at all because people kind of weren't even receiving it. So going to the newsletter first model proved to be very beneficial for us and our numbers. And also just reaching our freaking audience, which we were barely doing, I guess, on social media, which is, which is wild, you know, for, for a, an account that has a lot of followers, I forget at this exact moment, but we have a ton, double blind, has a ton of followers on, on Instagram. Mary Carreon: We were, we, we get like 500 likes or, you know, maybe like. I don't know. If you're not looking at likes and you're looking at views, like sometimes we get like 16 K views, which, you know, seems good, but also compared to the amount of followers who follow us, it's like not really that great. And we're never reaching new, like a new audience. Mary Carreon: We're always reaching the same audience too, [00:17:00] which is interesting because even with our news, with our, with our email list, we are still reaching new people, which is, which says just how much more fluid that space is. Mm-hmm. And it's because it's, because censorship does not at least yet exist in our inboxes. Mary Carreon: And so therefore email is kind of like the underground, if you will, for this kind of content and this type of material journalism, et cetera. So, so yeah. So it, it, it has been a massive shift. It is required a lot of changes over at double blind. Everything has been very intense and crazy, but it has been absolutely worth it, and it's really exciting that we're still here. Mary Carreon: I'm so grateful that Double-Blind is still around, that we are still able to tell stories and that we are still able to work with writers and nurture writers and nurture the storytelling in this space because it needs to evolve just the same way that the industry and the [00:18:00] culture and everything else is evolving. Joe Moore: Yeah, I think, I think you're spot on like the, when I watch our Instagram account, like, um, I haven't seen the number change from 107 K for two years. Mary Carreon: Absolutely. Same. And, um, same. Joe Moore: Yeah. And you know, I think, I think there's certain kinds of content that could do fine. I think, uh, psychedelic attorney, Robert Rush put up a comment, um, in response to Jack Coline's account getting taken down, um, that had some good analysis, um. Joe Moore: Of the situation. Go ahead. You had No, Mary Carreon: no, I'm just like, you know, I can't, when, when journalists are getting kicked off of these, of these platforms for their stories, for their reported stories, that's like, that is a massive red flag. And that's all I have to say. I mean, we could go into more, more details on that, but that is a [00:19:00] huge red flag. Joe Moore: Mm-hmm. Yeah. Um, for sure. The, I, yeah. And like I'm sure he'll get it back. I'm sure that's not for good, but I think he did. Okay, great. Mary Carreon: I think he did. Yeah. Yeah, I think he did. Joe Moore: Yeah. So thank you. Shout out to Jack. Yeah, thanks Jack. Um, and I think, you know, there's, there's no one with that kind of energy out there. Joe Moore: Um, and I'm excited to see what happens over time with him. Yeah. How he'll unfold. Absolutely unfold. Oh yeah. It's like, um. Crushing the beat. Mary Carreon: Oh yeah, absolutely. Especially the political, the political beat. Like, there's no, there's few people who are really tackling that specific sector, which is like mm-hmm. Mary Carreon: So exciting for a journalist. Joe Moore: Yeah. Um, so model shifting, like we all have to like, adapt in new ways. Kyle and I are still trying to figure out what we're gonna do. Like maybe it is newsletter first. Like I, I realized that I hadn't been writing for [00:20:00] years, which is problematic, um, in that like, I have a lot of things to say. Mary Carreon: Totally. Joe Moore: And nobody got to hear it. Um, so I started a substack, which I had complicated feelings about honestly. 'cause it's just another. Rich person's platform that I'm, you know, helping them get Andreessen money or whatever. And, you know, so I'm gonna play lightly there, but I will post here and there. Um, I'm just trying to figure it all out, you know, like I've put up a couple articles like this GLP one and Mushrooms article. Mary Carreon: I saw that. I saw that. Really? And honestly, that's a really, like, it's so weird, but I don't, like, it's such a weird little thing that's happening in the space. I wonder, yeah, I wonder, I wonder how that is going to evolve. It's um, you know, a lot of people, I, I briefly kind of wrote about, um, psychedelics and the GLP, is that what it is? Mary Carreon: GLP one. Joe Moore: GLP one. Say Ozempic. Yeah, just, yeah, Ozempic. Yeah, exactly. Mary Carreon: Yeah, exactly. I wrote about [00:21:00] that briefly last year and there were a bunch of people like obviously horrified, which it is kind of horrifying, but also there's a bunch of people who believe that it is extremely cutting edge, which it also is. Mary Carreon: So it's really interesting, really fascinating. Joe Moore: Yeah. Um, I remember Bernie Sanders saying like, if this drug gets as much traction as it needs to, it will bankrupt Medicaid. I guess that's not really a problem anymore. Um, but, but, uh, but so like naming it real quick, like it changed the way we had to digest things, therefore, like mushrooms get digested differently and, um, some people don't respond in the expected ways. Joe Moore: And then there was some follow up, oh, we, in the regulated model, we just do lemon tech. And then I was like, is that legal in the regulated model? And I, I don't know the answer still. Mm-hmm. Like there was a couple things, you know, if users know to do it, you know, I don't, I don't totally understand the regulated model's so strange in Oregon, Colorado, that like, we really need a couple lawyers opinions. Joe Moore: Right. I think Mary Carreon: yes, of course Joe Moore: the lawyers just gave it a [00:22:00] thumbs up. They didn't even comment on the post, which is, laughs: thanks guys. Um, Joe Moore: but you know, laughs: yeah. You're like, thank you. Joe Moore: Thanks and diversity of opinions. So yeah, there's that. And like GLP ones are so interesting in that they're, one friend reached out and said she's using it in a microdose format for chronic neuroinflammation, which I had never heard of before. Joe Moore: Whoa. And um, I think, you know, articles like that, my intent was to just say, Hey, researchers yet another thing to look at. Like, there's no end to what we need to be looking at. Abso Mary Carreon: Oh, absolutely, absolutely. You know, reporting on this space actually taught me that there's so much just in general that isn't being researched, whether that's in this space, but also beyond and how, um, yeah, just how behind, actually, maybe not, maybe behind isn't the right word, but it kind of feels from my novice and from my novice place in the, in the world and [00:23:00] understanding research, it's. Mary Carreon: Hard for me to see it as anything, but being behind in the research that we all really need, that's really going to benefit humanity. But also, you know, I get that it's because of funding and politics and whatever, whatever, you know, we can go on for days on all of that. Joe Moore: What's the real reason? What's the real reason? Joe Moore: Well, drug war. Mary Carreon: Yeah. Well, yeah, definitely the drug war. Nixon. Yeah. Yes, yes, definitely the drug war. Yeah. I mean, and just the fact that even all of the drug research that happens is, again, through the lens of addiction and drug abuse, so Joe Moore: mm-hmm. Hard to right. Yeah. Um, like ni a is obviously really ridiculous and, and the way they approach this stuff, and Carl Hart illustrates that well, and, Mary Carreon: oh man, yes, he does. Joe Moore: Like, I think Fadiman's lab in Palo Alto got shut down, like 67, 66 or 67, and like that's, you know, that was one of the later ones, Mary Carreon: right? And, Joe Moore: and like, Mary Carreon: and here we are. Joe Moore: The amount of suffering that could have been alleviated if we [00:24:00] had not done this is. Incalculable. Um, yes. Yes. Yeah. Mary Carreon: I mean the, yeah, it's hard to say exactly how specifically it would be different, but it's difficult to also not think that the fentanyl crisis and the opioid addiction rate and situation that is currently like plaguing the, the world, but particularly the United States, it's hard to think that it wouldn't be, like, it wouldn't be a different scenario altogether. Joe Moore: Right, right. Absolutely. Um, and it's, um, it's interesting to speculate about, right? Like Yeah. Yes. Where would we be? And Mary Carreon: I know, I know, I know, I know it is speculation. Absolutely. But it's like hard, as I said, it's hard not to think that things would be different. Joe Moore: Right. Right. Um, I like, there's two kind of quotes, like, um, not, this one's not really a quote. Joe Moore: Like, we haven't really had a [00:25:00] blockbuster psychiatric med since Prozac, and I think that was in the eighties or early nineties, which is terrifying. And then, um, I think this guy's name is James Hillman. He is kinda like a Jungian, um, educator and I think the title of one of his books is, we're a hundred Years Into Psychotherapy and the World is Still a Mess. Joe Moore: And I think like those two things are like, okay, so two different very white people approaches didn't go very far. Yes. Um, yes and laughs: mm-hmm. Joe Moore: Thankfully, I think a lot of people are seeing that. Mm-hmm. Um, finally and kind of putting energy into different ways. Um, Mary Carreon: yeah. Absolutely. I think, yeah, I mean, we need to be exploring the other options at this point because what is currently happening isn't working on many fronts, but including in terms of mental health especially. Mary Carreon: So mm-hmm. We gotta get going. Right? We [00:26:00] gotta get moving. Geez. Joe Moore: Have you all, have you all seen much of the information around chronic pain treatments? Like I'm, I'm a founding board member with the Psychedelics and Pain Association, which has a really fun project. Oh, that's interesting. Mary Carreon: Um, I've seen some of the studies around that and it's endlessly fascinating for obvious, for obvious reasons. Mary Carreon: I, um, we have a writer who's been working for a long time on a story, uh, about the chronic pain that has since. Become an issue for this, for her, for the writer. Mm-hmm. Um, since she had COVID. Mm-hmm. Since, since she is just like, COVID was the onset basically of this chronic pain. And, um, there she attended a psychedelics in pain, chronic pain conference and, uh, that has pretty much like, changed her world. Mary Carreon: Um, well, in terms of just the information that's out there, not necessarily that she's painless, but it's just, you know, offering a, a brand new, a brand new road, a brand new path that is giving her, [00:27:00] um, relief on days when the pain is, uh, substantial. laughs: Yeah. Mary Carreon: So that's interesting. And a lot of people are experiencing that as well. Joe Moore: Mm-hmm. So there's, there's a really cool set of overlap between the COVID researchers, long COVID researchers and the chronic pain people. 'cause there is Yes. This new science of pain that's yes. Our group, PPA put out like a really robust kind of training, um, for clinicians and researchers and even patients to get more educated. Joe Moore: And we're, we're getting, um, kind of boostered by cluster busters and we're kind of leveraging a lot of what they've done. Mary Carreon: Wait, what is a cluster buster? Joe Moore: Oh gosh. Um, so they're a 5 0 1 C3. Okay. Started with Bob Wald. Okay. Bob Wald is a cluster headache survivor. Oh, oh, oh, Mary Carreon: okay. Got it. Got it. Yes. So they're Joe Moore: the charity that, um, has been really championing, um, cluster headache research because they found a protocol [00:28:00] with mushrooms. Joe Moore: Yes, yes, yes. To eliminate. Mm-hmm. Yeah. Um, this really great, I Mary Carreon: love that. Joe Moore: This really great book was written by a Rutgers, um, I think medical sociologist or anthropologist psychedelic. Love laughs: that. Joe Moore: Joanna Kempner. Cool. Um, and it kind of talks about the whole, um, cluster busters saga, and it was, it was pretty cool. Joe Moore: Nice. So they've been at it for about as long as maps. Um, oh wow. Maybe a little earlier. Maybe a little later. Mary Carreon: I love that. Cool. I mean, yeah, that's really great. That's really great. Joe Moore: So we're copying their playbook in a lot of ways and Cool. We about to be our own 5 0 1 C3 and, um, nice. And that should be really fun. Joe Moore: And, uh, the next conference is coming up at the end of next month if people wanna check that out. Psychedelic. Nice. Mary Carreon: Nice, nice, nice. Cool. Joe Moore: Yeah, so that, like, how I leaned into that was not only did I get a lot of help from chronic pain with psychedelics and going to Phish shows and whatever, um, you know, I, and overuse for sure helped me somehow. Joe Moore: [00:29:00] Um, God bless. Yeah. But I, I like it because it breaks us out of the psychiatry only frame for psychedelics. Mm. And starts to make space for other categories. Mm-hmm. Is one of the bigger reasons I like it. Mary Carreon: Mm-hmm. Mm-hmm. Yes. Yes. Which, like, we need to be, we need to, we, no one else is gonna do it for us. We like the people in the space who are finding new uses for these substances need to be creating those, those pathways and those new niches for people to then begin studying, et cetera, and exploring and yeah. Mary Carreon: Making, making a proper avenue for, Joe Moore: right, right. And, you know, um, I don't know that this is a Maha thing, so No, I'm going there, I guess, but like, how do we kind of face squarely America and the world's drinking problems? Not [00:30:00] knowing what we know now about alcohol, you know what I mean? And then like, what are the alternatives? Joe Moore: You know, some, some writers out there on substack are very firm that everybody needs to not do any substance. And like all psychedelics are super bad and drugs are evil, you know, famous sub stackers that I won't name. But you know, like what is the alternative? Like, I, like we have to have something beyond alcohol. Joe Moore: And I think you've found some cannabis helpful for that. Mary Carreon: Yeah, I, you know, it's, it's interesting because it's, there are, there's definitely an argument to be made for the power of these substances in helping, I don't wanna, I don't wanna say curb, but definitely reduce the symptoms of, uh, wanting to use or to drink or to consume a specific substance. Mary Carreon: There's obviously there is an argument to be made. There are, there is ano another camp of people who are kind [00:31:00] of in the, in the, in the, in the realm of using a drug to get off of a drug isn't how you do it. However, and, and I do, it depends on the individual. It depends on the individual and the, and how that person is engaging with their own addiction. Mary Carreon: I think for whether or not the substances work, like whether psychedelics work to help somebody kind of get off of alcohol or get off of cocaine or stop using opioids or, you know, et cetera. Mm-hmm. However, I think like, when the situation is so dire, we need to be trying everything. And if that means, like, if, like, you know, if you look at the studies for like smoking cessation or alcohol use, mushrooms do help, psilocybin does help with that. Mary Carreon: Mm-hmm. But, you know, there's, there's a lot of, there's a lot of things that also need to happen. There's a lot of things that also need to happen in order for those, uh, that relief to maintain and to stick and to, uh, really guide [00:32:00] somebody off of those substances. Mm-hmm. It's not just the substance itself. Joe Moore: Right. So I'm, I'm explicitly talking like recreational alternatives, right. Like how do I Yeah. On per minute, like, am Anitas becoming helpful? Yeah, yeah. Are helpful and Yeah. Yeah. I think like even, um, normal. What we might call like normal American alcohol use. Like Yeah. That's still like, quite carcinogenic and like, um, absolutely. Joe Moore: We're kind of trying to spend less as a country on cancer treatments, which I hope is true. Then how do we, how do we develop things that are, you know, not just abstinence only programs, which we know for sure aren't great. Mary Carreon: Yeah. They don't work. Yeah. I don't, it's, it's difficult. Mm-hmm. It's difficult to say. Mary Carreon: I mean mm-hmm. I don't know. Obviously I, I, well, maybe it's not obvious at all for people who don't know me, but, you know, I exist in a, I exist in, in a world where recreational use is like, it's like hard to define what recreational use is because if we are using this, if we are using mushrooms or LSD even, or MDMA, [00:33:00] you know, there are so many, there's a lot of the therapy that can happen through the use of these substances, even if we're not doing it, you know, with a blindfold on or whatever and yeah, I think like. Mary Carreon: There is a decent swap that can happen if you, if you are somebody who doesn't wanna be, you know, having like three beers a night, or if you are somebody who's like, you know, maybe not trying to have like a bottle of wine at a night or something like that, you know, because like Americans drink a lot and a lot of the way that we drink is, um, you know, like we don't see it as alcoholism. Mary Carreon: Even though it could be, it could be that's like a difficult Joe Moore: potentially subclinical, but right there. Mary Carreon: Um, yeah. Yeah. It's like, you know, it's, um, we don't see it as that because everybody, a lot of people, not everybody, but a lot of people drink like that, if that makes sense. If you know mm-hmm. If you, if you get what I'm, if you get what I'm saying. Mary Carreon: So, you know, I do think that there's a lot of benefit that, I don't [00:34:00] know, having, like a, having a mushroom, having a mushroom experience can really help. Or sometimes even like low dose, low doses of mushrooms can also really help with, like, with the. Desire to reach for a drink. Yeah, totally. And, and AMS as well. Mary Carreon: I know that that's also helping people a lot too. And again, outside of the clinical framework. Joe Moore: Yeah. I'm, a lot of people project on me that I'm just like constantly doing everything all the time and I'm, I'm the most sober I've been since high school. You know, like it's bonkers that like Yeah. Um, and you know, probably the healthiest event since high school too. Joe Moore: Yeah. But it's fa it's fascinating that like, you know, psychedelics kind of helped get here and even if it was like For sure something that didn't look like therapy. Yeah, Mary Carreon: yeah, yeah, yeah. Absolutely. Absolutely. Yeah. I, I think, I think most of us here in this space are getting projected on as to like, you know, being like what Normies would consider druggies or something, or that we are just like, you know, high all the time. Mary Carreon: Um, [00:35:00] I know that that is definitely something that I face regularly, like out in the world. Um, but, you know, I would also, I would also argue that. Uh, like mushrooms have completely altered my approach to health, my approach to mental health, and not even having to consume that, you know, that substance in order or that, you know, that fun fungi, in order for me to like tap into taking care of my mental health or approaching better, uh, food options, et cetera. Mary Carreon: It's kind of like what these, it's like how the mushrooms continue to help you even after you have taken them. Like the messages still keep coming through if you work with them in that capacity. Right. And yeah, and also same with, same with LSD too. LSD has also kind my experiences with that have also guided me towards a healthier path as well. Mary Carreon: I, I understand that maybe for some people it's not that way, but, um, for me that substance is a medicine as well, [00:36:00] or it can be. Joe Moore: Yeah. Um, so. What are, what are some things popping up these days about like US drug policy that's like getting exciting for you? Like, are you feeling feeling like a looming optimism about a, a major shift? Joe Moore: Are you kind of like cautiously optimistic with some of the weird kind of mandatory minimum stuff that's coming up or? Mary Carreon: Yeah. Yeah. I mean, I know that there was a huge, a, a pretty huge shift over at the DEA and I wish I remembered, I wish I remembered his name. The new guy who's now, I believe the head of the DEA, I don't know enough information about it to really feel a way. Mary Carreon: However, I don't think that he's necessarily going to be serving us as a community here, uh, in the psychedelic space. I, you know, I just don't think that that's something that we can ever depend on with the DEA. Uh, I also don't think that [00:37:00] the DEA is necessarily going to be. All that helpful to cannabis, like the cannabis space either. Mary Carreon: Um, I know that, that Trump keeps kind of discussing or, or dangling a carrot around the rescheduling of cannabis. Um, for, he's been, he's been, but he's doing it a lot more now. He's been talking about it more recently. Uh, he says like, in the next like couple weeks that he's going to have some kind of decision around that, allegedly. Mary Carreon: But we will see also, I'm not sure that it's going to necessarily help anybody if we reschedule two. Uh, what from schedule one to schedule th two, three, schedule three. Joe Moore: Either way it's like not that useful. Right. Exactly. Mary Carreon: Yeah. Yeah, exactly. It's, um, just going to probably cause a lot more red tape and a lot of confusion for the state rec markets. Mary Carreon: So it's like something that we, it's like only ridden with unintentional, unintentional consequences. Unintended consequences. Mm-hmm. Because no one knows how it's really going to [00:38:00] impact anything, um, if, if at all. But I don't know. It's hard, it's hard to imagine that there won't be any, uh, like more complex regulatory issues for business owners and also probably consumers as well. Joe Moore: Hmm. Yeah. This guy's name's Terry Cole. Mary Carreon: Oh, the new DEA guy. Joe Moore: Yeah. Um, I don't know much about him. Terry. Yeah. Terry, I would love to chat. Mary Carreon: Yeah. Terry, let's talk. I'm sure your people Joe Moore: are watching. Yeah. So like, just let him know. We wanna chat. Yeah. We'll come to DC and chat it out. Um, yeah. It's, um, but yeah, I, Carl Hart's solution to me makes like almost most of the sense in the world to just end the scheduling system Absolutely. Joe Moore: And start building some sort of infrastructure to keep people safe. That's clearly not what we have today. Mary Carreon: No. But building an infrastructure around the health and wellness and uh, safety of [00:39:00] people is the exact opposite system that we have currently right now. Because also the scheduling system has a lot to do with the incarceration in the United States and the criminal just, or the criminal system. Mary Carreon: So, so yeah, like we can't disentangle the two really. Joe Moore: It just started, um, I feel negligent on this. Uh, synergetic press put out a book like a year or two ago called Body Autonomy. Mm-hmm. Um, did that one come across your desk at all? Mm-hmm. No. I wish basically contributed. Oh, nice. A number of people. So it's both like, um. Joe Moore: Drug policy commentary and then like sex work commentary. Oh, nice. And it was like high level, like love that really, really incredible love that detailed science based conversations, which is not what we have around this. Like, that doesn't make me feel good. So you should go to jail kind of stuff. Or like, I'm gonna humiliate you for real though. Joe Moore: Ticket. Yeah, Mary Carreon: yeah, yeah, yeah, yeah. Oh God. Uh, when you think about it like that, it just really also shows [00:40:00] just the uh, um, the level at which religion has also kind of fundamentally infused itself into the scheduling system, but also our laws, you know, like what you just said, this like, shame-based, I'm going to embarrass you and make you into a criminal when you know actually you are a law for the most part, a law abiding citizen, with the exception of this one thing that you're doing for. Mary Carreon: A, your survival and or your, like, your feeling good, wanting to feel good addressing pain. Um, there's a large, uh, like noise coming out of the front yard of my house right now. Hold on. Just a, it doesn't sound too bad. It doesn't sound too bad. Okay. Okay, good. Not at all. Not at all. Okay. Yeah, I had Joe Moore: people working on my roof all day and somehow it worked out. Joe Moore: Oh, good. Um, yeah. Um, yeah, it's, it's fascinating and I, I've been coming around like, I, I identify as politically confused, [00:41:00] um, and I feel like it's the most honest way I can be. Um, Mary Carreon: I am also politically confused these days, impossible to align with any, uh, party or group currently in existence at this exact juncture in American history. Joe Moore: I can't find any that I want to throw my dice in with. Nah. This idea of like fucking way being. Like what is the most humane way to do government as a way it's been put to me recently. And that's interesting. So it comes down to like coercion, are we caring for people, things like that. And um, I don't think we're doing it in a super humane way right now. Mary Carreon: Um, we, yeah, I am pretty sure that even if there was, I mean, I think that even if we looked at the data, the data would support that we are not doing it in a humane way. Joe Moore: So Mary Carreon: unfortunately, and Joe Moore: you know, this whole tech thing, like the tech oligarch thing, you kind of dropped at the beginning and I think it's worth bringing that back because we're, we're on all [00:42:00] these tech platforms. Joe Moore: Like that's kind of like how we're transmitting it to people who are participating in these other platforms and like, you know, it's not all meta. I did turn on my personal Facebook, so everybody's watching it there. I hope. Um, see if that count gets, Mary Carreon: um, Joe Moore: but you know, this idea that a certain number of private corporations kind of control. Joe Moore: A huge portion of rhetoric. Um, and you know, I think we probably got Whiffs of this when Bezos bought Washington Post and then Yes. You know, Musk with X and like yes. You know, is this kind of a bunch of people who don't necessarily care about this topic and the way we do, and they're like in larger topics too about humane government and like, you know, moving things in good directions. Joe Moore: Um, I don't know, thoughts on that rift there as it relates to anything you, wherever you wanna go. Yeah. Mary Carreon: Yeah. I mean, I don't think that they are looking at, I don't think that they are looking [00:43:00] at it the way that we are. I don't think that they can see it from their vantage point. Um, I think that like, in the, in a similar way that so many CEOs who run businesses have no fucking clue about what's actually happening in their businesses and the actual workers and, and employees of their businesses can tell them in more detail. Mary Carreon: Far more detail about what's actually happening on the, on the floor of their own business. Uh, I think that it is something like that. However, that's not to say that, you know, these, these CEOs who employ people who build the A algorithm are obviously guided to create the limitations on us as people who speak about drugs, et cetera, and are creating a algorithm that ultimately is looking at things in a very blanket way in terms of, uh, like we're probably seen on the same level as like drug dealers, if that makes sense. Mary Carreon: Which is obviously a much, you know, there's, [00:44:00] it's a very different thing. Um, so, you know, there's like these CEOs are giving directions to their employees to ultimately create systems that harm. Information flow and inform and, and like the information health of, of platforms and of just people in general. Mary Carreon: So it's hard to say because there's nuance there, obviously, but I would bet you that someone like Elon Musk doesn't really have a full grasp as to the, the nuances and details of what's even happening within, on the ground floor of his businesses. Because that's like, not how CEOs in America run, run, and operate. Mary Carreon: They're stupid companies. So, so yeah. And I feel like that, like, that's across the board, like that's across the board. That's how I, that's probably how Zuck is operating with Meta and Facebook, et cetera. And yeah, just likewise and across, across the whole, [00:45:00] across the whole spectrum. Joe Moore: Mm-hmm. Yeah. And I think, um, a thing. Joe Moore: Then as the people like, we need to keep looking at how can we keep each other informed. And that's kind of circling back to drug journalism like we do and like, um, other, other sorts of journalism that doesn't really get the press it deserves. Right. And I've been getting far more content that I find more valuable off of tragically back on Zucks platform like IG is getting me so much interesting content from around the world that no major outlet's covering. Mary Carreon: That's so interesting. Like what? Like what would you say? Joe Moore: Oh, um, uh, certain, um, violent situations overseas. Oh, oh, got it. Yeah, yeah, yeah. And, um, you know, that America's paying for, so like, you know, I just don't love that I don't have a good, you know, journalistic source I can [00:46:00] point to, to say, hey, like right. Joe Moore: These writers with names, with addresses, like, and offices here. Yes. You know, they did the work and they're held, you know, they're ethical journalists, so yes. You can trust them. Right. You know what I mean? Yes, Mary Carreon: yes. Yeah, yeah, yeah. I mean, all of this makes everything so much harder for determining, like, the censorship specifically makes it so much harder for the people to determine like, what's real, what's not. Mary Carreon: Because, because of exactly what you just said. Mm-hmm. Like, you know, we are, we are basically what that means, like what is required of the people and people who are consuming information is becoming a smart consumer and being able to determine what's real, what's not. How can we trust this individual? Mary Carreon: How can we not, which isn't analysis process that all of us need to be sharpening every single day, especially with the advent of AI and, uh, how quickly this, this type of content is coming at all of us. Like, especially if you're on TikTok, which many of us are, you know, like information comes flying at you 3000 miles an hour, and it's sometimes [00:47:00] really difficult to determine what's real, what's not, because AI is. Mary Carreon: AI is not where it's going to be, and it still is in its nascent phase. However, it's still pretty fucking good and it's still very confusing on there. So, so again, like the media literacy of the people needs to be sharpened every single day. We cannot be on there, we cannot be on the internet existing. Mary Carreon: That everything that we are seeing is real. Whether that's about, you know, these, um, the violence overseas, uh, happening at the hands of the United States, whether that is, uh, even drug information like, you know, et cetera, all of all of it. Or just like news about something happening at Yellowstone National Park or something that is happening in the, uh, at like. Mary Carreon: Um, like potential riots also happening at protests in downtown la, et cetera. Like all, all of it, we need to be so careful. And I think what that also, like, one way that [00:48:00] we can adjust and begin to develop our media literacy skills is talking to people maybe who are there, reaching out to people who are saying that they were there and asking them questions, and also sussing that out. Mary Carreon: You know, obviously we can't do that for all situations, but definitely some of them. Joe Moore: Yeah, absolutely. Like, Joe Moore: um, a quick pivot. Mm-hmm. Were you at PS 25? Mary Carreon: Yes, I was. What did I think? Uh, you know, I, I was running around like crazy at this one. I felt like I didn't even have a second to breathe and I feel like I didn't even have a second to really see anybody. I was like, worry. I was jumping from one stage to the next. Mary Carreon: However, I would say, uh, one of, one of the things that I have said and how I felt about it was that I felt that this, this event was smaller than it was two years ago. And I preferred that I preferred the reduction in size just because it was, uh, less over, less overwhelming [00:49:00] in an, in an already very overwhelming event. Mary Carreon: Um, but I thought that from the panels that I did see that everyone did a really great job. I thought that maps, you know, it's impressive that maps can put on an event like that. Um, I also was very cognizant that the suits were there in full effect and, uh, you know, but that's not unusual. That's how it was last time as well. Mary Carreon: And, um, I felt that there was Mary Carreon: a, uh, like the, the, the level of excitement and the level of like opportunity and pro, like the prosperous. The like, prospect of prosperity coming down the pipeline like tomorrow, you know, kind of vibe was different than last time. Mm-hmm. Which that was very present at the one, two years ago, uh, which was the last PS psychedelic science. Mary Carreon: Yeah. Um, anyways. Yeah. But it was, you know, it was really nice to see everybody. [00:50:00] I feel like in-person events is a great way for everybody in the psychedelic space to be interacting with each other instead of like keyboard warrioring against each other, you know, uh, over the computer and over the internet. Mary Carreon: I think that, um, yeah, uh, being in person is better than being fighting each other over the internet, so, yeah. Joe Moore: Mm-hmm. People seem to be a little bit more civil in person. Mary Carreon: Exactly. Exactly. Mm-hmm. And I think that that is something that we all need to be considering more often, and also inviting people from across the aisle to your events and creating peace, because in person it's a little different than it is. Mary Carreon: When you have the opportunity to, uh, yeah, like keyboard attack someone over the internet, it's like, yeah. It's just so silly. So silly. We look like fools. Like we look like absolute idiots doing that. And you know what? I cannot sit here and say that I haven't looked like an idiot. So, you know, it's like I'm not, I'm not talking from like a high horse over here, but, but you know, it's like, it's [00:51:00] better when it's in person. Mary Carreon: I feel like there's like more civil engagements that we can all have. Joe Moore: It's practice, you know? Yeah. We're learning. Yeah. We are. We should be learning, including us, and yes, of course. Um, I, I play a subtler game these days and, uh, you know, I, I, I, it's better when we all look a lot better in my opinion, because yes, we can inform policy decisions, we can be the ones helping inform really important things about how these things should get implemented and absolutely right. Joe Moore: Like, Mary Carreon: absolutely. Yeah, it does. It does. Nobody, any service, especially these medicines, especially these sacraments, especially these plants, these molecules, et cetera, if we are all sitting here fighting each other and like calling each other names and trying to dunk on one another, when like in reality, we are also all kind of pushing for the same thing more or less. Joe Moore: Mm-hmm. So a thing that [00:52:00] I, it's a, it's kind of a, I, I had a great time at PS 25. I have no, no real complaints. I just wish I had more time. Yeah, same. Um, same. Yeah. Our booth was so busy. It was so fun. Just good. And it was like, good. I, I know. It was really good. I'm trying to say it out loud. I get to talk at the conference before Rick did. laughs: Oh, oh, Joe Moore: the morning show they put us on at like seven 30 in the morning or something crazy. Oh my god. It was early. I dunno if it was seven 30. Mary Carreon: That's so early. That's so early. Joe Moore: Yeah, right. Like that's crazy. I got zero nightlife in That's okay. Um, I was not, I was there for work. Yeah, Mary Carreon: yeah. I was Joe Moore: jealous. I didn't party, but you know, whatever. Joe Moore: Yeah, yeah. Mary Carreon: I did not party this time really in the same way that I did at PS 20. Was it 2023? Joe Moore: 23, yeah. 23. I only stay up till 11 one night in 23. Nice. Mary Carreon: Okay. Um, okay. Joe Moore: So I behaved, I have a pattern of behaving. 'cause I like That's good. I'm so bent outta shape inside going into these things. I'm like, I know, I know. Joe Moore: And, and I'm like, oh, all [00:53:00] my friends are gonna be there. It's gonna be great. And then it's like, yeah. It's mostly friends and only a little bit of stress. Yeah. Um, yeah. Yeah, Mary Carreon: yeah. I had a, I had a great time. It was really good seeing everybody again. Like you, I wish that I had more time with people. Like there are people that I like didn't even see who are my friends, Joe Moore: so, which Yeah. Joe Moore: Which is sad. That's like a subtext in, in like the notes coming away from 25. Is that the, um, American Right, if we wanna call it that, is very interested in this stuff. Oh yeah. Like the Texas establishment. Oh yeah. Um, the Texas contingent, right? They're deep. They're real deep. Mm-hmm. I have, um, Mary Carreon: let's talk about that more. Mary Carreon: Yeah. So Joe Moore: it's optimistic in, in some sense that psychedelic science is getting funded more. By states. 'cause the feds aren't stepping up. Right. I love that. Right. Yeah. Like, Hey feds, look what we can do. And you can't somehow, and [00:54:00] then, um, we'll see if state rights stays around for a while longer, maybe, maybe not. Joe Moore: And then the other part is like, is there a slippery slope given the rhetoric around addiction and the rise in interest in iboga for compulsory addiction treatment with psychedelics or, or compulsory mental health treatments with psychedelics because of the recent, it's illegal to be a person without housing. Joe Moore: Um, and you're gonna get put in treatment. Mm. Like, that's now a thing. So like, I don't know, I don't think forced treatment's good at all. I, and I don't think like, um, like the data is something like 15% effective, maybe less. Right. Right. It's not a good use of money. I don't know. We're, let's, I. You can go there if you want, and riff on that, or if you wanna talk about like, Texas, um, Arizona more generally. Mary Carreon: Yeah. I mean, I will just say this, I also don't really believe that forced treatment is like good, you [00:55:00] know, data Joe Moore: says it's bad. Mary Carreon: Yeah. Yeah. I also, yeah, I mean, it's like, I don't know. Yeah, that's, it's complex. It's a complex issue. I also don't think it's good, but I also do think that we need a much better framework and foundation for like, if people do want the help, helping them get it. Mary Carreon: Much more easily and in a way that's going to be beneficial for them. Um, and I don't think that that system or that pathway currently exists as we saw in, uh, with, with, um, measure 1 0 9 and the failure of measure 1 0 9 or, or was it Measure 1 0 10, 1 10, measure one 10 in Oregon. Joe Moore: But did you see the response yesterday or two days ago? Joe Moore: No, I didn't. No, I didn't. I'll I'll send it to you later. Okay. So the university did the research, um, Portland State University did the research Yes. And said, Hey, look, there was actually 20 other things that were higher priority. Like that actually influenced this increase in overdoses, not our law. Mary Carreon: Right. Mary Carreon: Yes. It was really COVID for Okay. [00:56:00] Like for, yeah. Right. Absolutely. Also, there was not a. Like there was not a framework in place that allowed people to get off the street should they want to, or you know, like, like you just can't really have a, all drugs are legal, or small amounts of drugs are legal without also offering or creating a structure for people to get help. Mary Carreon: That, that's, you can't do one without the other. Unfortunately. That's just like a, that's faulty from the start. So that's all I'll really say about that. And I don't think that that had fully been implemented yet, even though it was something that wasn't ideal for the, um, for the, for the measure. And I believe it was measure one 10, not measure 1 0 9, to be clear. Mary Carreon: Measure one 10. Um, yes, but confirmed one 10 confirmed one 10, yes. Mm-hmm. Um, but yeah, uh, that's, you know, that's kind of what I'll say. That's what I'll, that's where I'll leave that portion. Mm-hmm. You know? Uh, but yeah, forced treatment. I don't know. [00:57:00] We can't be forcing, forcing people to do stuff like that. Mary Carreon: I don't know. It's not gonna, it's, yeah, it doesn't seem Joe Moore: very humane. Mary Carreon: Yeah. No. And it also probably isn't gonna work, so, Joe Moore: right. Like, if we're being conservative with money, like, I like tote, like to put on Republican boots once in a while and say like, what does this feel like? And then say like, okay, if we're trying to spend money smartly, like where do we actually get where we want to be? Joe Moore: And then sometimes I put on my cross and I'm like, okay, if I'm trying to be Christian, like where is the most, like, what is the most Christian behavior here in terms of like, what would the, you know, buddy Jesus want to do? And I'm just like, okay, cool. Like, that doesn't seem right. Like those things don't seem to align. Joe Moore: And when we can find like compassionate and efficient things, like isn't that the path? Um, Mary Carreon: compassionate and t. Yeah, even, I don't know, I don't know if it looks lefty these days, but Yeah, I know what you mean. Yeah, I know what you mean. I know what you mean. Yeah. [00:58:00] Yeah. Um, yeah, it's complicated. It's complicated, you know, but going back, kind of, kind of pivoting and going back to what you were talking about in regards to the subtext, some of the subtext of like, you know, where psychedelic medicine is currently getting its most funding. Mary Carreon: You know, I do believe that that was an undercurrent at psychedelic science. It was the, the iboga conversation. And there's, there's a lot, there's a lot happening with the Iboga conversation and the Iboga conversation and, um, I am really trying to be open to listening to everyone's messages that are currently involved in. Mary Carreon: That rise of that medicine right now? Um, obviously, yeah, we will see, we'll see how it goes. There's obviously a lot of people who believe that this is not the right move, uh, just because there's been no discussions with, uh, the Wii people of West Africa and, you know, because of [00:59:00] that, like we are not talking to the indigenous people about how we are using their medicine, um, or medicine that does like that comes from, that comes from Africa. Mary Carreon: Um, also with that, I know that there is a massive just devastating opioid crisis here that we need to do something about and drug crisis that we need to be helping with. And this medicine is something that can really, really, really help. Um, I find it absolutely fascinating that the right is the most interested party in moving all of this forward, like psychedelic medicine forward. Mary Carreon: And I, I currently have my popcorn and I am watching and I am eating it, and I am going to witness whatever goes down. Um, but I'm, I, I hope that, uh, things are moving in a way that is going to be beneficial for the people and also not completely leave behind the indigenous communities where this medicine comes from. Joe Moore: [01:00:00] Mm-hmm. Mary Carreon: We'll see how it goes. Yeah. We'll see how it goes. We'll see how it goes. It Joe Moore: would be lovely if we can figure it out. Um, I know, and I think, uh, Lucy Walker has a film coming out on Iboga. Mm. I got to see it at Aspen, um, symposium last summer, and it was really good. Mm. So I'm sure it'll be cut different, but it's so good and it tells that story. Joe Moore: Okay. Um, in a helpful way. I'm gonna, I, yeah. I always say I'm gonna do this. I'm like, if I have space, maybe I'll be able to email her and see if we can screen it in Colorado. But it's like a brilliant film. Yeah. Cool. This whole reciprocity conversation is interesting and challenging. And so challenging being one of the few countries that did not sign onto the Nagoya protocol. Joe Moore: Absolutely. We're not legally bound, you know, some countries are Mary Carreon: I know. Yes, yes, yes. So Joe Moore: we're, you know, how do we do that? How do we do that skillfully? We still haven't done it with, um, first Nations folks around their [01:01:00] substances. Um, I think mushrooms are a little flexible and account of them being global, um, from Africa to Ireland and beyond. Joe Moore: And, but you know, that's, we still want to give a nod to the people in Mexico for sure. Yeah, absolutely. Absolutely. Yeah. Um, yeah. Yeah, it's, I had some fun commentary there that I would love to flesh out someday. Uh, but yeah, it's not for today. Mary Carreon: Yeah, yeah, yeah. Um, there's, yeah, there's obviously, there's obviously a lot with the conversation of reciprocity here and, um, I know, I, I don't know. Mary Carreon: I, I, what I do know is that we need to be listening to the indigenous people, not just listening to them second, like secondhand or listening to them, uh, once we have moved something forward, like actually consulting with them as the process goes. And that, you know, the way that both parties move, indigenous folks and, uh, western folks move, uh, are at inherently different paces. Mary Carreon: And, [01:02:00] um, I just hope, and I wish, and I, I hope, I just hope that, uh, Western what, like the Western party, the western folks who are diving into these medicines. Slow the fuck down and listen and just are able to at least make one right move. Just one, just like you. Like it's, doesn't have to be this, it doesn't have to be that hard. Mary Carreon: Although the pace of capitalism usually propels, uh, the western folks at, at a much quicker rate than, u

The Dime
Largest Medical Cannabis & Cancer Study Ever: Can These Findings Push Rescheduling? ft Ryan Castle

The Dime

Play Episode Listen Later Sep 25, 2025 48:40


If you were given some of the worst news in the world, wouldn't you expect your doctors to use every tool available?What if one of those tools could save millions of lives—and the science is already here?The world's largest medical cannabis and cancer study—10,000 papers, ranked in the top 5% globally—shows overwhelming evidence that cannabis has medical benefits. If fully embraced, its impact on patients and medicine could be transformative. As science continues to unfold, sometimes it takes skeptics to dive deep and uncover what's truly there, even when powerful interests push back.This week we sit down with Ryan Castle, Research Director at Whole Health Oncology Institute, to discuss:Medical cannabis: efficacy, placebo, and why it matters less than you thinkHow this study is being used in rescheduling effortsHow vested interests fuel anti-cannabis researchChapters00:00 Introduction to Medical Cannabis Research03:06 Ryan Castle's Journey into Cannabis Research05:58 The Meta-Analysis Process Explained09:00 Understanding the Data and Its Implications11:54 Skepticism and the Shift in Perspective15:01 Consensus in Medical Cannabis Research18:04 Nuances in Cancer Treatment and Cannabis20:55 Biomarkers and Inflammatory Responses22:56 Exploring Cannabis and Cancer Outcomes29:37 Bridging the Gap: Patient-Reported Outcomes35:32 The Future of Medical Cannabis Research45:34 The Cancer Playbook: Empowering Patients SummaryIn this episode, Bryan Fields and Kellan Finney engage with Ryan Castle, Research Director at Whole Health Oncology Institute, to explore the evolving landscape of medical cannabis research. Ryan shares his journey from skepticism to advocacy, detailing the extensive meta-analysis he conducted on the efficacy of cannabis in treating various symptoms and conditions, particularly in oncology. The conversation delves into the challenges of measuring effectiveness, the importance of patient-reported outcomes, and the need for a shift in medical perspectives towards cannabis as a legitimate treatment option. Ryan emphasizes the potential impact of policy changes and the importance of transparency in research, while also discussing the Cancer Playbook initiative aimed at empowering patients with data-driven insights. TakeawaysRyan Castle initially set out to prove that cannabis doesn't work.His extensive research revealed that cannabis is effective for a wide range of conditions.The meta-analysis included over 10,000 studies and 800,000 data points.Cannabis showed efficacy not just for symptoms but also for cancer treatment.Patient-reported outcomes are crucial for understanding cannabis effectiveness.The study found that cannabis can help reduce opioid dependency.There is a significant need for a shift in medical perspectives on cannabis.Transparency in research is essential for building trust in findings.The health impact assessment could reveal the broader benefits of cannabis.The Cancer Playbook initiative aims to empower patients with data-driven insights.Guest Linkshttps://wholehealthoncologyinstitute.com/Our LinksBryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.

Air Tight 148: Black Pumas, Weed Rescheduling & Hemp in Beer? | Eclectic Music + Culture Show

"In My Grow Show"

Play Episode Listen Later Sep 8, 2025 90:31


     Air Tight 148 brings another mind-expanding mix of underground music, eclectic sounds, and counter-culture conversation, curated by the one and only The Alex—only on Green Coast Radio.      This week, The Alex takes listeners on a sonic journey through the freshest underground hits, featuring tracks from Black Pumas, Dylan Smuckers, Omega Nebula, Vaguess, 7 Year Bitch, and more.  Expect a genre-blending ride of underground beats, dance tracks, and off-the-radar gems that you won't find on the mainstream.

Cannabis Legalization News
The MORE Act Returns, Rescheduling Rumors, and State Showdowns

Cannabis Legalization News

Play Episode Listen Later Aug 31, 2025 48:11


Send us a textCannabis Legalization News: Key Updates, Rescheduling Speculations, and Federal DevelopmentsThis episode of Canvas Legalization News covers various topics surrounding cannabis reform, rescheduling, and federal policy changes. It discusses the potential impact of Trump's plan to reschedule marijuana and reviews the historical challenges of the MORE Act in Congress. The episode also touches on local legislative issues such as the Delaware Governor's zoning veto and Texas' struggle with cannabis regulations. Notable segments cover public figures' reactions to cannabis use, economic analysis of the hemp sector, and the push for federal policy change through rescheduling to achieve more comprehensive legalization in the future.00:00 Introduction and Weekly Overview00:23 Main Stories: Cannabis Reform and More Act03:44 Discussion on Rescheduling vs. Descheduling06:04 Challenges in the Cannabis Industry10:07 Federal Policy and Market Dynamics13:34 Bloomberg News Analysis and DEA Regulations20:04 State-Level Issues and Taxation23:52 The Arbitrary THC Limit25:06 Challenges for Farmers26:16 Texas Hemp Legislation30:22 Cannabis at the US Open33:16 Economic Impact of Hemp37:03 Roger Stone and Cannabis Rescheduling40:31 Final Thoughts and MerchSupport the showGet our newsletter: https://bit.ly/3VEn9vu

Chillinois Podcast
#228 - Illinois DUI Scandal and Federal Rescheduling Rumors

Chillinois Podcast

Play Episode Listen Later Aug 30, 2025 96:45


In this episode of The Cole Memo, we dig into the fallout from ABC7 Chicago's latest report on the University of Illinois Chicago's forensic testing lab. Flawed cannabis DUI testing has put thousands of convictions under scrutiny, raising serious questions about oversight and justice in Illinois. We also look at the ongoing debate around cannabis rescheduling at the federal level, including recent comments from President Trump and reactions from industry leaders and opponents alike. Plus, updates on the Texas hemp ban and another troubling Illinois cannabis raid highlight how prohibition still lingers despite legalization. Watch video version and read full show notes here: https://thecolememo.com/2025/08/29/e228/

Clearing The Haze
Episode #130 What Rescheduling Marijuana Means for Employers and Leaders

Clearing The Haze

Play Episode Listen Later Aug 29, 2025 42:42


In this episode of Clearing the Hayes podcast, host Chuck Marting dives into the critical issue of rescheduling marijuana from a Schedule One to a Schedule Three drug under federal law. Chuck, an experienced leader in impairment recognition and workplace safety, dissects the nuances and far-reaching consequences this change could bring. The episode explores the potential impacts on company risk management, employee testing, and public safety.Chuck emphasizes the importance of evolving beyond outdated zero-tolerance policies towards a 'zero blind spots' approach, encouraging leaders to recognize impairment proactively and protect their companies, employees, and communities. Real-life case examples and legal changes across various states are discussed to illustrate the complex landscape. Ultimately, the episode calls for immediate action and training to prepare leaders for the shifting legal and workplace environment.00:00 Introduction to the Podcast00:46 The Impact of Rescheduling Marijuana02:28 Legal and Business Implications05:19 Workplace Policies and State Laws08:39 Challenges in Detecting Impairment14:34 Real-Life Cases and Consequences26:37 The Zero Blind Spots Leadership Model36:27 Conclusion and Call to Action

Cannabis Legalization News
Did Trump just flip on weed?

Cannabis Legalization News

Play Episode Listen Later Aug 24, 2025 57:05


Send us a textJoin Tom Howard for this week's episode of Cannabis Legalization News, where we dive into the significant developments in cannabis policy, including former President Donald Trump's potential plans to reschedule cannabis. We examine the impact of this move on current laws, the tax burdens on license holders, and the future of federal cannabis policy. We also look at how cannabis legalization is evolving through state policies and court rulings. Plus, we touch on the cultural portrayal of cannabis in media, such as a recent South Park episode, and discuss how this could influence public perception and legalization efforts. Stay tuned for updates, guest appearances, and a whole lot more!00:00 Introduction to Cannabis Legalization News00:09 Trump's Potential Shift on Cannabis Policy01:22 Political Landscape and Cannabis Legislation11:28 Cannabis and Second Amendment Rights14:06 Commercial Break and Legal Insights23:57 South Park's Take on Cannabis Rescheduling28:24 Public Consumption Laws in DC30:03 Federal Employees and Marijuana Legalization30:58 Illegal Marijuana Plants in National Parks32:38 Marijuana Raids and Public Reactions34:53 Name That Strain: Alpha Express36:38 Illinois Vape Market and Tax Issues40:39 Legalization and Federal Policy Challenges46:43 Rescheduling and Its Implications54:57 Final Thoughts and ShoutoutsSupport the showGet our newsletter: https://bit.ly/3VEn9vu

Terpene Therapy
Terpene Therapy #186: Preparing for Technofascism, Rescheduling, and a Beautiful Hike!

Terpene Therapy

Play Episode Listen Later Aug 21, 2025 48:15


This week we take a hike with a RekTip roll in a very beautiful wildflower sanctuary! I found the RekTip while preparing the recovery room for my wife and I figured I might as well feature it on an episode! I got that tip while I was experiencing an ego clash at Ego Clash '24! A lot of energy stored in that glass to say the least! I also discuss the changing landscapes of both our digital environment and the scheduling of cannabis in this country; be prepared for changes on both ends and never stop fighting for what is right! Keeping the power in the hands of the people and out of the hands of the corporate-owned government! Terps N Things! RekTip 12mm full color tipElements King Size WideTerp Style - Cheesequake FlowerOff The Paddle - Tropaya 73-119uThank you for listening and please make sure you check out all of our social medias and subscribe to our YouTube and Patreon!https://www.instagram.com/terpenetherapytimecapsulehttps://www.patreon.com/terpenetherapypodcasthttps://www.youtube.com/channel/UCIuE6pg63WB2dwZ--1SgTig/featuredDisclaimer: This is an educational Podcast with comedic attributes to educate and entertain the viewer about my Life. In this video, I walked around a few places and documented my experience, and gave each location a rating. In certain parts of the Podcast, My Visual Effects team used Green Screen and CGI (Computer Generated Imagery) to simulate smoke, for comedic effect and expression. There is no real smoke in this video, and every viewer of the Podcast knows this. This is not the main focus of the video, just as a comedic expression in this larger Podcast. My special effects team works hard to make everything realistic while leaving a hint of artistic expression, to make the smoke simulations noticeably fake. This Podcast has been endorsed as educational content to educate and teach the viewer. Thank YouSupport the show

The John Phillips Show
The Feds are considering rescheduling marijuana

The John Phillips Show

Play Episode Listen Later Aug 19, 2025 35:56


Do you think legalizing pot in California was a mistake?See omnystudio.com/listener for privacy information.

Cannabis Legalization News
Cannabis Legalization News - Week Ending August 17, 2025

Cannabis Legalization News

Play Episode Listen Later Aug 17, 2025 55:24


Send us a textJoin Tom, a seasoned cannabis lawyer, as he delves into the latest in cannabis legalization news for the week ending August 17, 2025. In this episode, Tom discusses the ongoing complexities of cannabis remaining a Schedule I substance, despite ongoing debates and potential rescheduling to Schedule III. Tom also shares insights from the week's main stories, including Donald Trump's surprising comments on cannabis and legislative developments in Texas. Furthermore, the podcast explores the challenges and unpredictability of home growing cannabis, the influence of hemp regulations, and new research on vaping products. Stay tuned for insightful discussions on regulatory hurdles, and the evolving landscape of legal cannabis.00:00 Introduction and Podcast Goals01:07 Streamy Yard Updates and Main Story Tease01:48 Trump's Cannabis Comments and Rescheduling Speculations05:11 Homegrown Cannabis Challenges11:41 Texas Cannabis Legislation and Industry Insights17:04 Advocacy for Sensible Cannabis Regulations26:42 Trucking Industry Concerns and Cannabis Testing29:08 Debating Cannabis Impairment Rules29:37 Political and Social Commentary30:06 Rescheduling and Prohibition Issues31:02 Challenges in Cannabis Legislation32:09 Technical Difficulties and Show Banter36:40 Hemp and Seed Industry Concerns40:22 Pharmaceutical Regulations and Cannabis46:20 Vaping Products and Health Risks52:00 Final Thoughts and Future PlansSupport the showGet our newsletter: https://bit.ly/3VEn9vu

Clearing The Haze
Ep#129 Workplace Safety at Risk- The Hidden Dangers of Rescheduling Marijuana

Clearing The Haze

Play Episode Listen Later Aug 15, 2025 13:22


The Implications of Rescheduling Marijuana: A Workplace Safety PerspectiveIn this episode of Clearing the Hayes, host Chuck Marty discusses the potential rescheduling of marijuana from a Schedule I to a Schedule III drug and its repercussions on workplace safety. Drawing from his extensive experience in training professionals to detect and handle impairment, Marty emphasizes the increased risks of impairment with high-THC marijuana, which could impact cognitive functions, reaction times, and decision-making. Chuck warns about the consequences for safety-sensitive roles and the potential for legal and cultural shifts in the workplace. Additionally, Marty highlights the influence of the marijuana industry in pushing for rescheduling for financial gain, while urging business owners, safety managers, and HR professionals to advocate for explicit protections to ensure workplace safety. The episode concludes with a call to action to contact lawmakers, reinforce drug-free workplace policies, and train supervisors to recognize impairment.00:00 Introduction to the Podcast00:18 The Potential Reclassification of Marijuana01:00 Understanding Marijuana Rescheduling02:01 The Risks of High-Potency Marijuana04:10 Implications of Rescheduling for Workplace Safety07:11 The Financial Motives Behind Rescheduling08:07 Action Steps for Employers and Safety Managers11:13 Conclusion and Call to Action

Breaking Points with Krystal and Saagar
8/13/25: Saagar Vs Trump Marijuana Rescheduling, Orthodox Nun Slams Israel With Tucker Carlson

Breaking Points with Krystal and Saagar

Play Episode Listen Later Aug 13, 2025 42:12 Transcription Available


Saagar and Emily discuss Trump rescheduling Marijuana, an Orthodox Nun slams Israel with Tucker Carlson, and Zohran Mamdani slams Andrew Cuomo for ties to Jeffrey Epstein. To become a Breaking Points Premium Member and watch/listen to the show AD FREE, uncut and 1 hour early visit: www.breakingpoints.com Merch Store: https://shop.breakingpoints.com/See omnystudio.com/listener for privacy information.

High on Home Grown, The Stoners Podcast
Brits Jailed in Zimbabwe | Cannabis & Psilocybin Risks | Oral Cancer Link | UK Prescribing Concerns | Trump Eyes Rescheduling

High on Home Grown, The Stoners Podcast

Play Episode Listen Later Aug 11, 2025 63:56


In this week's episode of High on Home Grown, we cover the biggest cannabis news from around the world: Macky reports on two Brits jailed in Zimbabwe after being caught smuggling cannabis. He also looks at new research suggesting that using cannabis and psilocybin together could increase the risk of dependence. Margaret shares a concerning study showing cannabis use disorder may triple the five-year risk of developing oral cancer. Billy discusses the UK's Care Quality Commission raising concerns over cannabis prescribing practices after data revealed a 130% surge in prescriptions. John wraps up with political news from the US, where Trump is reportedly considering reclassifying marijuana to a less dangerous category under federal law. Join us for another packed episode full of global cannabis headlines, medical insights, and policy developments you need to know about. Come and join in the discussion about any of these news articles on our cannabis growing forum, Discord server, or any of your favourite social networks. Visit our website for links.

Chillinois Podcast
#225 - Trump Considers Cannabis Rescheduling, Illinois Opens New Social Equity Loans

Chillinois Podcast

Play Episode Listen Later Aug 11, 2025 13:47


In this special episode of The Cole Memo, Cole breaks down breaking news on both the federal and state levels. At the federal level, President Trump has confirmed that his administration is “looking at” rescheduling marijuana, with a decision expected within the next few weeks. We review his comments, the political and industry reactions, and what rescheduling could mean for research, the cannabis industry, and 280E tax burdens. Meanwhile, in Illinois, the state has opened applications for the third round of its Cannabis Social Equity Loan Program, offering financial support to eligible licensees. Cole shares details on how to apply, resources for applicants, and more. Join the conversation as we explore what could be one of the most significant moments in cannabis policy in recent years. Watch video version and read full show notes here: https://thecolememo.com/2025/08/11/e225/

Cannabis Legalization News
Trump Rescheduling Rumors and Global Developments

Cannabis Legalization News

Play Episode Listen Later Aug 10, 2025 56:40


Send us a textCannabis Legalization News: Trump Rescheduling Rumors and Global DevelopmentsJoin Tom and MGI on another episode of Cannabis Legalization News! This week, they delve into the buzzing rumors about former President Trump considering rescheduling marijuana to Schedule III. They also cover various stories, including Californian tax hikes in San Diego, a hemp feud between two Kentucky senators, and the difficult cannabis rollout in New York. Special guest Kristen Barry discusses the upcoming 'Science in the City' conference in Bordeaux, France, and the evolving landscape of cannabis law and advocacy in Europe.00:00 Introduction and Weekly Highlights01:46 Technical Difficulties and Live Interaction02:23 Trump's Rescheduling Plans06:26 California's Cannabis Tax Issues07:42 Kentucky Hemp Showdown14:45 France's Cannabis Legalization29:57 State Cities Named After Other Countries30:18 Cannabis Rescheduling and Federal Legalization30:59 Expert Opinions on Federal Legalization31:58 Challenges in the Cannabis Industry32:28 The Impact of Rescheduling on Federal Policy34:43 The Issue of Unregulated Cannabis Products40:42 The Role of Regulation and Testing47:31 Future of Cannabis Legalization53:06 Closing Remarks and Future PlansSupport the showGet our newsletter: https://bit.ly/3VEn9vu

Blunt Business
Anthony Coniglio of NewLake Partners on Optimistic Cannabis Policy, Rescheduling, and State Hemp Regulations

Blunt Business

Play Episode Listen Later Aug 6, 2025 41:51 Transcription Available


Anthony Coniglio, CEO at NewLake Partners returns to discussed a possible shifting to an optimistic outlook on cannabis policy, noting concerns about Rand Paul's efforts to strip hemp language from the agriculture appropriations bill and a proposed DOJ rule classifying cannabis users as "dangerous to society." We also covered DEA Administrator Terrence Cole's confirmation, his strategic priorities not including cannabis rescheduling, and the potential impact of Schedule 3 reclassification on addressing transnational criminal organizations, with Anthony clarifying that the DEA's priorities align with the National Drug Threat Assessment. The participants also discussed the rescheduling process and timeline, and the actions taken by states to ban or regulate intoxicating hemp-derived THC products.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

The Franciska Show
Where Are the Adults? Navigating Youth Mental Health Crises with Leigh Ioffe

The Franciska Show

Play Episode Listen Later Aug 3, 2025 62:56


In this episode of the Franciska Show, Leigh Ioffe, a crisis management specialist and founder of the nonprofit organization The Long Short Road, shares her journey and work in the realm of mental health and crisis intervention. Lee discusses her accidental entry into the field, which began with her work at the Chabad Teen Network and evolved into addressing the mental health needs of young people dealing with suicidal ideation. She elaborates on the unique challenges faced by the Orthodox Jewish community, including religious guilt and trauma, and emphasizes the importance of combining mental health support with religious guidance. Lee also provides insights from her extensive training and experience, including the development of bespoke suicide prevention programs and the importance of relational support in crisis management. She shares personal stories of success and resilience, illustrating the profound impact of compassionate human connections. Additionally, Leigh offers practical advice for individuals and community leaders on how to provide support to those struggling with mental health issues, ensuring they feel safe, seen, and soothed.   00:00 Welcome to the Franciska Show 00:19 Accidental Path to Crisis Management 01:11 Religious Journey and Family Background 02:46 Challenges in Mental Health Awareness 08:46 Warm Line: A Support System 17:53 Expressive Writing for Healing 23:26 Training and Future Plans 32:47 Rescheduling and Learning New Things 33:32 Nuances of Addressing Suicidal Ideation 36:45 Training and Crisis Management 39:21 Balancing Nonprofit Work and Personal Life 43:52 The Importance of Sensitivity in Mental Health 56:00 Final Thoughts and Key Takeaways       About Our Guest: Leigh Ioffe is a crisis management specialist and dedicated advocate for individuals navigating mental health challenges. She is the founder and director of The Long Short Road, where she leads the creation of psycho-educational programs, warmline services, and consultations that offer personalized support to hundreds each year. Leigh's work is grounded in compassion and practical care, helping people access the tools they need to heal and grow. Beyond her professional role, Leigh is a wife, a mother to two daughters, and a published fiction author. She is also currently pursuing certification as a mindfulness practitioner, further enriching her holistic approach to well-being.   www.linkedin.com/in/leigh-ioffe-25785149  Instagram and Facebook: @thelongshortroad   www.JewishCoffeeHouse.com  

Happy Hour Podcast with Dee and Shannon
EP 233 Lead Retreats Without Losing Yourself: The Joy Factor with Kelley Hartman

Happy Hour Podcast with Dee and Shannon

Play Episode Listen Later Jul 31, 2025 20:25


In this heartfelt and empowering episode of The Retreat Leaders Podcast, host Shannon Jamail sits down with Kelley Hartman to explore the transformative power of joy in retreat leadership. Kelley shares how a life-changing diversity retreat in her twenties sparked her passion for holding space and eventually led her to create her own retreats focused on joy, self-care, and aligned leadership. Together, Shannon and Kelley dive deep into why joy is not just a nice-to-have, but a non-negotiable for any retreat leader who wants to avoid burnout and truly support others. They get candid about energy management, setting boundaries, and honoring your nervous system—especially when life throws challenges your way. Whether you're a seasoned retreat host or dreaming of starting your first one, this episode reminds you that when you prioritize your own joy and well-being, you elevate the experience for everyone you serve.   Offerings from Kelley: Free 4 Step Outline to reset into joy: https://kelley-hartman.mykajabi.com/wildhartscollectivejoyresetsignup    Connect with Kelley: https://wildhartscollective.com/   The Retreat Leaders Podcast Resources and Links: Learn to Host Retreats Join our private Facebook Group Top 5 Marketing Tools Free Guide Free Top 11 Tips for Building an Email List  Get your legal docs for retreats   Thanks for tuning into the Retreat Leaders Podcast. Remember to subscribe for more insightful episodes, and visit our website for additional resources. Let's create a vibrant retreat community together!   Subscribe:  Apple Podcast | Google Podcast | Spotify   --------------------------------------------------- Automatically Transcribed With Podsqueeze Speaker 1 00:00:00  Welcome to the Retreat Leaders podcast, your sanctuary with retreat experts. Where we spill the tea on retreat. Success. Here we dive into crafting transformational guest experiences. Talk about how to avoid pitfalls and unlock marketing secrets. Whether you're a seasoned guru or a budding enthusiast, we've got the inside scoop for you. Join us as we learn how to flourish in this magical world of retreats. Hey guys, welcome to or welcome back to the Retreat Leader's podcast. It's Shannon and today I have such a special guest, although I have to preface it by saying this is not as fun as France because my guest is someone that I met while I was in France, and we were just saying right before we recorded that it was such a magical group and I missed that energy so, so very much. But I'm really excited to see you today. Kelly, welcome to the show. Speaker 2 00:00:54  Thank you. Very excited to be here. Speaker 1 00:00:58  Yes. So Kelly Hartmann and I are going to talk about something that probably seems a little bit like. Speaker 1 00:01:04  Wait a minute, Shannon, why are you talking about this? But I actually feel like it's super, super important for us as retreat leaders and what we do and how we serve. And it's just a very, very important aspect of our leadership. But before we dig into the topic, Kelly, just tell us about who you are and what brought you to where you are today. Speaker 2 00:01:22  Great. Yeah. So I'm Kelly Hartman and I own Wild Hearts Collective, and I am a retreat leader. So the journey there is a little bit of a long one. I went to my first retreat in my 20s, and what really sparked my lifelong desire to host retreats was the amount of transformation that happens when you're on retreat. I met people there that I still connect with today, and that's 25 years later. and basically just learning the personal lived journeys needs of everyone there is what was life changing for me. It was a diversity retreat and it was getting that individual perspective. So when I hit 45, I said, I'm going to do what I wanted to do my whole life. Speaker 2 00:02:11  I'm going to host retreats. And I was also in corporate. I already host leadership trainings. I created Elevate Her, I host the global mentorship program and did a lot of trainings and learning and development for corporate women. So I'm taking that out of practice and doing it and hosting retreats of my dreams. So that is why I started. Speaker 1 00:02:36  Yay! You know what I love about this is that over 20 years ago, you had the spark and you're bringing it to fruition. And I think sometimes people, whether you're 40, 50, 60, 70, it doesn't even matter whatever your age is. But women, especially whatever that number is, that age in our head and we're like, yeah, I'm too old to do this now, you know? And I just, I call bullshit on that because there isn't an age that's too old. There just isn't. Okay. There isn't. And so, Kelly, I'm so, so glad that you were following your dreams now. And you're hosting these retreats because. Speaker 1 00:03:16  Yeah, I met Kelly in France, as I mentioned, and her energy is yummy. Like, I just cannot even put it into proper words. And so spending time with her on retreat, I'm sure, would be a joy, which is exactly what we're going to talk about today, because Kelly and I in France, we were talking about some of the things that might be missing from a retreat leader's life, as far as you know, being the best version of them. And one of those things is focusing on joy. So, Kelly, can you just kind of talk to us a little bit more about this? Speaker 2 00:03:50  Oh for sure. So as a retreat leader, you are facilitating the transformation of others on your retreat. And when you're doing that, that is having a requirement for you to hold space. And a lot of times, especially right now. Everything is so the world is messy and it's heavy. And every five seconds there's breaking news about something. And what that does is that triggers our nervous system to go into fight or flight. Speaker 2 00:04:22  And it makes all of this anxiety and worry and fear come into our energetic field and build up in us. And when we have all this heaviness and fear and anxiety and we dysregulated our nervous system, that is what causes us to basically not be able to hold that space. As retreat leaders, we need to know how to step out of the grind, to step out of burnout to start with self-care so that we when we show up on retreat, we are the best version of ourselves. And that's when we talk about anchoring into joy. Because what is joy and what is required for you to actually experience joy? You have to feel safe, right? You have to feel your nervous system has to feel good for you to even get to experience joy. And once you get there, that is when expansiveness comes. That is when you're in flow. That is when you can give and pour into other people's cups. Speaker 1 00:05:37  Hey, retreat leaders, pause that retreat planning for just a second because I've got something you do not want to miss. Speaker 1 00:05:42  I'm headed to London this October to host a live event that's all about teaching you how to host a retreat that's not just transformational, but actually profitable. Imagine sipping tea or champagne with other like minded leaders while mapping out your next sold out retreat. It's happening at the gorgeous Waldorf Hilton in London. I'm spilling all the secrets from pricing to planning, marketing to mindset, and you'll walk away with a strategy you can actually use. No fluff, no BS, just results. So head to Retreat mastermind and come join me across the pond. Okay, I love this on so many levels. You are right, the world is messy. That's a really good way of putting it. I think the world's always messy, but it just feels extra loud. You know, at the moment. we've definitely in our lifetime, Kelly, we have seen some extra loud moments. probably. Maybe. You know, I'm sure more than previous decades. Only in the sense even that it's just so damn accessible. Too accessible in some ways. Speaker 1 00:06:43  Yeah. But yes, that and also I want to piggyback on this because as Kelly knows, this last month has been really very difficult for me. I've had some losses and and when we're in those spaces, whether it's heaviness from the world and our nervous system is disruptive or very personalized heaviness and we're disrupted. I think it's important that we remember that's not the time to create when we're in that space, when we're in that space of full disruption, full nervous system panic, whatever you want to call it. That's not the time to reach out. That's as far as reaching out to your, marketing efforts or your creation efforts or whatever may be the case. Maybe that's when you rely on a team member and you're like, hey, I need you to step up for me, or you hire it out for that moment, or you just take a break. But it's like, we need to honor that. There are times in life we're going to push, right? We're going to push through things. Speaker 1 00:07:38  You know, you stub your toe, push through it, whatever. But there are also times when your nervous system is telling you, okay, we we can't we can't go on. You know what I'm saying? Speaker 2 00:07:48  Yes. And it's so important that we learn to honor that in ourselves, because we have to learn how that we can honor that in our participants and see that and help them through that. In a lot of times, especially in the world right now, it's the hustle bustle. We got to go. We're we're women entrepreneurs, right? So we have a lot of big goals, a lot of big dreams. And I know that we hustle a lot. We're always kind of like, I gotta get this done and do that. And we don't take or make the space always to breathe, to anchor in, to return to our body out of our mind. And that causes those cortisol levels to rise, the anxiety, the panic. And it takes a toll on your physical and mental health and is so important for us to listen to our body, to rest like you said, to take a break and rest and recalibrate Because we're able to come back stronger than before. Speaker 2 00:08:48  It's so important. Speaker 1 00:08:51  Yeah. This is such a good reminder to me sometimes I forget. And I think many of our listeners forget that it doesn't always have to be pushed through it. It reminds me when I used to have my private practice for mental health. If I sat with a particularly heavy session with a client, I had to work really hard to reset myself so I didn't take it into the next session. It wouldn't be fair to that next patient for me to bring the previous patient's heaviness to them, right? And it's the same aspect here, Kelly, especially for those of us who are holding space. I'm just going to say it. You really should not be bringing your heaviness into the space that other people are trying to share their heaviness. It's just not appropriate. I know people are listening, are going to disagree with me. They're going to think, well, that's a safe space for everybody to do it. You know what? Yes, but not for the leader. The leader has to do their own processing, their own leaning in, their own resetting. Speaker 1 00:09:44  Separate. It really is. That is not the time and space for you to bring your heaviness in. It really alludes the whole point of a retreat for the guests that are paying to participate with you as a leader. It's okay to say, hey, I'm experiencing heaviness today. We're going to start our workshop a little bit later and then you do your thing. I'm not saying that you're going to show up and pretend like everything's okay. That's not what I'm saying. What I'm saying is, you're not bringing your shit into the same space that everybody else is trying to hold their heaviness or share their stuff, and, and I just I'm super passionate about that. And this is a really good reminder for myself as well. Speaker 2 00:10:23  100%. And that's and this is what I definitely want to talk about that this is not toxic positivity. This is not you should be enjoy every single day. And if you're not, enjoy it because that's bullshit. That is total bullshit. What this is, is that this is a reminder that we have tools and that to use those tools to really listen to your body and recalibrate your energy. Speaker 2 00:10:46  You own your experience on this planet, and when you choose to be a retreat leader, you're choosing to guide others and help them in their experience. And it's absolutely correct. You need to go in able to facilitate transformation. If you're in your own shit, you can't facilitate that transformation. You just you have to deal with that first. And having those tools to reset into joy, into calibrate to that is huge. It allows you to be expansive. It allows you to hold energy and space for others and allow them on their journey for transformation. Speaker 1 00:11:23  Yes. Thank you for this topic. I think it's so very important, and it's just one of those things that's often overlooked. as I shared, things have been really heavy with me, and one of the decisions that I made this August, I was having my retreat leader mastermind, and I'm actually Rescheduling it because it's just not the right time for me to hold space for others because I'm bringing my shit with me. And so I'm super transparent about that and making sure that, you know, I'm making decisions that are sound for my body and safe for me, but also for my guests. Speaker 1 00:11:58  I am still having my alumni retreat. for those that don't know what that is, is every other year, sometimes three years, but usually every other year, I host a retreat that's just for alumni. That means they've been on my retreat before. They know exactly who I am and what's going on. And I had a real heart to heart with myself and the group, and they are well aware of what I'm going through. And this is just a party. It's just a gathering. There's no transformation, there's no promise. There's no holding space necessarily. We're just coming together to celebrate. And we're all very excited about it. And I'm actually excited about it. My alumni retreat, because I just I feel safe with them just as much as they feel safe with me. And it's, you know, there's there's just a really good, And, it's just a really good vibe with this group and it's just going to be so fun. But I've really honored. The thing that I've put forth that I'm saying is I'm not creating anything in this time. Speaker 1 00:12:48  In this time. This time of my own heaviness. It's not fair to the people who might be receiving receiving it, but also they're not going to receive the, the, the my true heart right now. They're going to receive my broken heart or my grief heart or my guilt heart or whatever it is that I'm feeling inside. That's what they're going to receive. And that's not that's not representative who who I am. And so whether it's big like the world or like loss or anything like that, or whether it's just you struggle with sadness sometimes or you struggle with whatever, you know, or you've got, you know, difficulties in an important relationship, whatever that that is, you've got to lean into that and not bring it with you into your transformative spaces. And I think you, you know, you, Kelly especially, you offer tools and thoughts on how you can maybe tune out of that darkness. Speaker 2 00:13:42  Yes. Yeah, because we do have those. And first I want to say, thank you for sharing that and being vulnerable because you're setting an example and telling people that it's okay to pivot. Speaker 2 00:13:55  you know, when I work with women, both inside and outside of corporate, there's a lot of fear about, perception or quote unquote feeling, which is such bullshit. Sorry. But in that if we don't do things the way that we thought, if we don't, if we pivot, that's a failure. But you are actually doing something amazing for both you and the attendees and doing it in a space that will be transformative for them and bringing your best self when you can. So that's that's setting a huge example for everyone. And that's just amazing. So thank you for sharing that. Speaker 1 00:14:34  Hey, it's Shannon here. I'm just popping in really quickly to ask a big favor. Would you pause the show and go review it for us, please? Reviews really help us to be able to get more guests and more experts on the show to help you transform your retreats. So if you wouldn't mind pausing and leaving us a review, that would mean everything. And if you're not already subscribed, do that too. Speaker 1 00:14:56  Yeah. No, absolutely I, I really I. My, my motto is to try to walk the talk. And so what I teach I really I really do want to walk and I it was a really hard message to send to the attendees for August. and it was really it's been really hard, even for those that keep inquiring about it. but also feels right. It's hard, you know, the hard that feels right. That's what this is. This is the hard that feels right. And so I want my thing was, especially I had this conversation with an attendee who was really disappointed. But my thing was I want to show up and give my best self. I don't want to bring this and set it on your plate. or or do a half ass, you know, retreat for you. That's just not okay. And so anyway, so yeah, I feel really good about it. As hard as it is, I don't feel good about it. I feel good that the decision was the right decision to make. Speaker 1 00:15:52  just like I feel good that spending time with my retreat alumni who are coming tomorrow and I can't wait to see them. feels also very good, because I know that that's not going to require me holding space necessarily. My team can do it if that needs to be happening, but most my alumni retreats, I'm just going to be honest. It's just a party. It's a girl party. Speaker 2 00:16:11  That's awesome. So, so. And that is what we talk about a lot right now. And what I do is I gather the women we're gathering, the women gathering women in circles is so important and amazing. and just that space. But again, it's that that awesome and just radical honesty that you have, that this is what this experience is. It's not a retreat. It's a party. And that is. Yeah, that's exactly what will be expected of attendees. And they're excited to see you. They've already been through that transformation with you. And they they understand. So that is totally amazing. Speaker 1 00:16:48  Yes. Speaker 1 00:16:49  Yeah it really is. And plus the outpouring of love from them has been just beautiful. So, well Kelly, tell us, like if somebody wants to spend more time with you because I think that they would benefit from it greatly. Tell me some of the offerings that you currently have. Speaker 2 00:17:03  Sure. So I am hosting a retreat in September called Joy as Revolution and we are taking, this experience is amazing because it's allowing people to experience joy in different ways. So joy isn't always this exciting, passionate, like, oh, I'm in joy. I take everyone through the four elements. so how do you feel in Earth as you're experiencing joy. And that's a grounded joy of feeling stable or air. How does air feel? That's going to be light and that's doing breathwork and feeling alive. Or if you look at fire, fire is that passion. That's the creativity. So that's doing art, that's dancing, that's, you know, yelling at the moon, that fiery. And then last is water. Speaker 2 00:17:52  And that's when you're in flow and you let go of the things that we hold so deep. So the transformation that's coming there and what I specialize in, and that's with all of my offerings, is getting you out of your head and into your body. Your body knows. And you talked about that you felt into your decisions about both retreats. Your intuition told you what was right and you listened. And what I see so much in women is we ignore intuition because societal expectations tell us No. You should push through this. You should act a certain way. We have these expectations of how you show up and how you act. So I specialize in getting women to get into their bodies so they can transform and listen and learn and feel. And then they trust their intuition. And that is when the magic happens. Speaker 1 00:18:50  Oh, yes. Thank you. And may I have another I love this so much. And I will have Kelly's website linked in the show notes. So that way you can go check out her offerings. Speaker 1 00:19:00  And I think you even have a free gift for our listeners. Do you want to tell us a little bit about the free gift? Speaker 2 00:19:05  Yeah, it's my four tips to a joy reset. So it's exactly that. It's just an easy little thing that you can do really quickly. It has, some reprogramming and I'm certified. So it just is something that helps you get out of the loops that we have, those thought loops or anxiety or fear and gets you into your body so you can anchor into joy and you can visualize your best self and live as that self. And it's under five minutes. So really easy little quick thing. Speaker 1 00:19:34  Yay. Well that will also be linked in the show notes. So Kelly, thank you so much for coming on the show and just reminding us of what we need to be really focusing on as effective leaders in our industry, rather than just the metrics or social media or the right offering or the right workshop or all of these things that we think are super important and they are important to a certain degree. Speaker 1 00:19:58  But really, it all starts with our inner joy. So thank you so much, Kelly, for being on the show. Speaker 2 00:20:05  Oh, thank you so much, Shannon. I greatly appreciate it. Speaker 1 00:20:08  Thanks for listening to the Retreat Leaders podcast. Learn more at the Retreat. Com. See you next time.

The Prepper Broadcasting Network
The Continuity Rescheduling for Later this Week

The Prepper Broadcasting Network

Play Episode Listen Later Jul 29, 2025 4:31


Cannabis Legalization News
The Week in Cannabis Legalization: New DEA Head, Rescheduling Updates, and Prisoner Advocacy

Cannabis Legalization News

Play Episode Listen Later Jul 27, 2025 70:17


Send us a textIn this episode of Cannabis Legalization News, covering the week ending July 27, 2025, we delve into several key topics. The show kicks off with news about the new head of the DEA, Terry Cole, who replaces Anne Milgram. A primary focus is on the ongoing discussions regarding cannabis rescheduling to Schedule III and the implications of this potential change. The hosts emphasize the importance of legalization and the latest court rulings, particularly highlighting the case of Kan Devon Baxter and how Second Amendment rights intersect with cannabis use. They also share insights on the complexities of federal and state cannabis laws, discussing an interesting Supreme Court case on unconstitutional vagueness related to cannabis and firearm possession. Additionally, the show features an interview with Stephanie Shepherd from the Last Prisoner Project, discussing their advocacy efforts to release and support incarcerated individuals affected by cannabis laws. Shepherd shares her personal story of being imprisoned for cannabis and the challenges of resettling post-incarceration. They conclude with exciting legislative news about a new congressional bill, the Ship Act, which aims to allow interstate shipment of marijuana through USPS, potentially revolutionizing the industry for small and homestead producers. Tune in for an engaging discussion packed with important information, personal stories, and the latest updates in cannabis legalization!00:00 Introduction and Show Format01:17 Main Story: DEA Updates and Schedule Three01:43 Discussion on DEA Head and Legal Processes06:04 Collateral Base and Legal Challenges14:53 Interview with Stephanie Shepherd36:44 Trump's Absence and Regrets36:56 Pinch Write History Campaign37:40 Governor West Moore's Pardons38:11 Politics and Cannabis Legalization38:48 Odor Mitigation Policies39:17 Justice and Cannabis Reform39:49 Legalization and Hemp Market40:44 Legislation and FDA Challenges42:39 Letter Writing Campaigns44:12 Pardons to Progress Campaign45:26 Advocacy and Clemency Efforts46:20 Three Strikes Law and Harsh Sentences48:46 Challenges in Cannabis Legislation54:11 Rescheduling and Policy Changes01:00:05 Cannabis Legalization News PodcastSupport the showGet our newsletter: https://bit.ly/3VEn9vu

Cannabis Legalization News
What does the One Big Beautiful Bill Mean for Cannabis Legalization?

Cannabis Legalization News

Play Episode Listen Later Jul 6, 2025 66:17


Send us a textCannabis Legalization News: Major Updates, Legislative Insights, and Industry TrendsIn this episode of Cannabis Legalization News, the host discusses the latest news and legislation affecting cannabis legalization. Topics include a new bill, the One Big Beautiful Bill Act, which aims to legalize cannabis and its implications on tax cuts and healthcare. The program also covers federal and state regulatory updates, including issues with crop inversion, testing lab fraud, and changes to medical cannabis access for individuals with drug convictions. The episode highlights the importance of rescheduling cannabis to Schedule III to facilitate comprehensive research. Additional segments discuss developments in various states like Illinois, Utah, Georgia, Nebraska, and Mississippi, focusing on licensing and market changes. Viewers are encouraged to interact via super chats and explore consulting services for navigating the complex cannabis legal landscape.00:00 Introduction and Brand Refresh Tease00:19 Cannabis Legalization News Overview00:46 The One Big Beautiful Bill Act01:04 Congress and Cannabis Legislation01:42 Co-Host Introduction and German Community02:12 Fiscal Policies and Healthcare Cuts02:56 Donald Trump and Viewer Engagement03:19 Farm Bill and Budget Reconciliation03:39 Rescheduling and Project 202504:04 Interactive Show and Super Chats04:30 Farm Bill Video Discussion05:52 Hemp Industry and Legal Challenges08:55 Cannabis Legalization and Federal Policy14:41 Cannabis Industry Updates and Licensing23:42 Cannabis Research and Medical Benefits27:07 New Cannabis Strains and Reviews30:03 Cannabis Recall and Inversion Issues34:24 Illegal Cannabis Sales in West Peoria34:39 Trampoline Park School Controversy34:52 VIP Vapes and Illicit Cannabis Trafficking35:12 Consumer Apathy and Hemp Products35:47 New York Cannabis Recall Expansion36:05 Utah's New Medical Cannabis License37:51 DEA Rescheduling and Legal Implications42:21 Georgia's Medical Marijuana Hearings43:30 Nebraska's Medical Cannabis Regulations56:07 Bankruptcy and Cannabis Licensing Issues59:54 Florida's Medical Cannabis Access Restrictions01:01:23 Scientific Research and Cannabis Legalization01:05:08 Conclusion and Future ProspectsSupport the showGet our newsletter: https://bit.ly/3VEn9vu

The Dime
Trump, Texas SB3 & the Rescheduling Timeline: Jim Higdon on What Comes Next

The Dime

Play Episode Listen Later Jun 27, 2025 48:46


Prohibition is dead — and Texas just proved it.The recent SB3 vote signaled the start of something much bigger.While hemp and cannabis operate in very different styles, both are ultimately pushing toward the same goal: a sensible framework for a one-plant solution.The how? I'll leave that to people way smarter than me.But the genie is NOT going back in the bottle — and while speed and clarity aren't often associated with Congress, we might see that sentence written sooner than expected.This week, we sit down with Jim Higdon to discuss:The massive implications of Texas' SB3 voteWhat signals to watch for from TrumpWhat a “one-plant” solution could look likeChapters00:00 Introduction to the Cannabis Landscape03:03 The Regulatory Cage of Cannabis05:09 The Struggles of MSOs and Independent Operators08:24 Advocating for Policy Change10:15 The Role of the FDA and Future Regulations12:43 The Future of Cannabis Regulation15:04 Understanding the Texas Political Landscape17:58 The Power Dynamics in Texas Politics21:08 The Implications of the Texas Veto23:53 The Role of Public Perception26:09 The Economic Impact of THC in Texas29:45 The Influence of Trump and Federal Oversight30:14 The Path to Rescheduling Cannabis34:31 The Future of the Farm Bill36:00 The Optimistic Outlook for Cannabis SummaryIn this episode, Jim Higdon discusses the complexities of the cannabis and hemp industries, focusing on regulatory challenges, the political landscape in Texas, and the future of cannabis legislation. He emphasizes the need for collaboration between the hemp and cannabis sectors to navigate the evolving regulatory environment and advocates for a more unified approach to cannabis policy. The conversation also touches on the economic implications of THC products and the influence of political figures like Trump on the future of cannabis regulation.   Guest Links:https://www.cornbreadhemp.com/https://hempsupporter.com/team/jim-higdon/https://x.com/jimhigdonhttps://www.linkedin.com/in/jameshigdon/Our Links Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterAt Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.Sign up for our playbook here:

Cannabis Legalization News
Cannabis Legalization News: Father's Day Special & Rescheduling Update!

Cannabis Legalization News

Play Episode Listen Later Jun 16, 2025 76:33


Send us a textIn this episode of Cannabis Legalization News, hosts Tom and Miggy bring you the latest updates despite a delayed start due to Father's Day celebrations. They discuss a range of topics including a crazy story from the Marijuana Herald about possible marijuana rescheduling by the Trump administration. The importance of cannabis regulation, veterans' support, and the political landscape of cannabis legalization are some of the focal points. They touch on the inconsistent enforcement and regulation of hemp-derived products, the role and importance of home grows, and the declining cannabis stock market. Guest appearances and future plans for the show are also discussed. Special shout-outs go to veterans and fathers everywhere on this special day.00:00 Introduction and Father's Day Celebration01:18 Main Story: Marijuana Rescheduling02:50 Political Landscape and Legalization06:32 Hemp Industry and Legal Loopholes24:17 Home Grows and Genetic Diversity29:03 Cannabis Use Disorder and Legal Challenges32:33 Tribal Legalization and State Regulations39:40 Living in a New Place40:24 Retail and Regulation40:55 Nebraska's Cannabis Commission42:09 State Legislation and Bureaucracy43:49 Commercial vs. Homegrown Cannabis44:06 Cannabis Strains and Effects46:25 Texas Cannabis Legislation47:24 Hemp Industry Challenges50:38 Cannabis Activism and Legalization51:14 Cannabis Business Insights53:36 Cannabis Community and Market01:03:19 Cannabis Rescheduling and Federal Legalization01:04:45 Cannabis Consumption Trends01:15:28 Final Thoughts and Father's Day WishesSupport the showGet our newsletter: https://bit.ly/3VEn9vu

High on Home Grown, The Stoners Podcast
DEA Refuses to Back Rescheduling | Trump Ally Targets Medical Cannabis | Patient Reviews Under Fire | California Cannabis Tax Hike! | Cannabis News Episode

High on Home Grown, The Stoners Podcast

Play Episode Listen Later May 5, 2025 71:46


This week on the Cannabis News: Billy asks: Can patients trust online reviews in the medical cannabis sector? A closer look at the reliability of user feedback and its role in shaping public opinion. Macky reports on a cannabis farm bust in Prescot, uncovered after a neighbor noticed suspicious activity from a blind twitching “aggressively.” (Source: BBC News) John examines Trump's former U.S. Attorney, known for his anti-cannabis stance, now turning his attention toward medical marijuana policy again. California's Governor Gavin Newsom finalizes a 26% cannabis tax hike, drawing criticism from advocates and industry leaders. Margaret covers a big development at the federal level: the DEA's likely new administrator refuses to commit to moving cannabis to Schedule III, despite mounting pressure. Join us for insight and analysis on how these headlines could shape cannabis access, regulation, and public perception worldwide. Come and join in the discussion about any of these news articles on our cannabis growing forum, Discord server, or any of your favourite social networks. Visit our website for links.  Website: https://highonhomegrown.com Discord: https://discord.gg/sqYGkF4xyQ Youtube: https://www.youtube.com/highonhomegrown Thank you for downloading and listening to our cannabis podcast! I hope you enjoy this episode.

Cannabis Legalization News
Cannabis Legalization Update: DEA Changes, Social Equity, & State Developments

Cannabis Legalization News

Play Episode Listen Later May 4, 2025 69:08


Send us a textIn this episode of 'Cannabis Legalization News,' we discuss a wide range of topics including the potential rescheduling of cannabis by the DEA under Trump's nominee NCE Cole, the significance of the French existentialist Albert Camu in the cannabis legalization context, and the intricacies of social equity licenses in Washington State. Key highlights include the debate over the federal rescheduling of marijuana, state-specific cannabis laws from Rhode Island and New Hampshire, and the economic implications of the declining hemp market. We also touch on the latest news from Texas regarding hemp regulations and explore the potential public health benefits of cannabis legalization according to a JAMA study. The show is filled with in-depth analysis, expert insights, and some humorous takes on the evolving cannabis landscape. Don't miss our updates on important legislative changes and industry trends.00:00 Introduction and Weekly Update00:30 Main Story: DEA Rescheduling Cannabis01:22 Catholic Upbringing and Humor02:14 Senate Confirmation Hearing Insights05:43 Mixed Signals from Trump's Administration09:35 Social Equity and Legalization Challenges18:15 Hemp Industry and Market Dynamics34:37 Texas Cannabis Legislation Update35:51 Texas Cannabis Regulations and Public Response36:48 Critique of Texas Compassionate Use Program37:02 Impact of Rescheduling on Texas Cannabis Industry38:47 Veterans and Cannabis Marketing Ethics46:31 Federal Rescheduling and Gun Ownership58:08 Challenges in Cannabis Licensing and Market Dynamics01:02:49 Rhode Island and New Hampshire Cannabis Legislation01:06:14 Conclusion and Upcoming Cannabis LegislationSupport the show

WCR Nation | The Window Cleaning Podcast
Rescheduling for Window Cleaning Business Success | WCR Nation Ep. 411 | Window Cleaning Podcast

WCR Nation | The Window Cleaning Podcast

Play Episode Listen Later Apr 25, 2025 31:51


This week on WCR Nation, Jersey breaks down something that way too many window cleaners ignore—the SKILL of rescheduling. Yeah, you heard that right… it's not optional. It's a skill. And if you're not doing it, you're basically gambling with your business.

Cannabis Legalization News
DEA STALLS Rescheduling?! | Metrc Whistleblower EXPOSED | Florida Bans Delta-8?!

Cannabis Legalization News

Play Episode Listen Later Apr 13, 2025 70:51


Send us a textCannabis Legalization News: Bad News, Misleading Lawsuits, and MoreIn this episode of Cannabis Legalization News, the hosts discuss the tough week for cannabis news as Congress takes a two-week break, leaving no significant updates. They dive into the seventies' decriminalization trends abruptly halted by Reagan, drawing parallels to modern-day policies under Trump. The main story revolves around a lawsuit aiming to reschedule cannabis through an administrative hearing. The discussion also covers the DEA's rescheduling updates, the lengthy process for DEA filings, and various pending legal battles. The hosts touch on the increasing frustration with illicit THC sales merging into the alcohol industry and the promising judicial victories. As always, there's some humor and personal anecdotes, such as microphone issues and the exhaustion of dealing with court cases. Other topics include prospective cannabis legislation in Pennsylvania, concerns surrounding unsafe cannabis driving, potential rescheduling outcomes, and the varied perspectives on cannabis regulation at federal and state levels. The episode wraps up with a note on potential regulation shifts and the challenges faced by cannabis businesses in an evolving legal landscape.00:00 Introduction and Weekly Overview00:35 Historical Context and Current Legal Battles01:36 DEA Rescheduling Update02:11 Legal Challenges and Corporate Litigation03:47 Industry Dynamics and Big Alcohol's Influence06:33 Federal Rescheduling and Legalization Debate16:44 Home Growing and Consumer Concerns22:17 State-by-State Legalization Efforts28:56 Federal Regulations and the Future of Cannabis33:11 Understanding the Three-Tier Alcohol Regulation System34:18 The Definition and Regulation of Hemp35:00 Strain Discussion and Cannabis Culture37:00 Challenges in Growing Cannabis40:02 Federal and State Cannabis Regulations52:27 The Role of Seed-to-Sale Tracking59:10 Closing Remarks and Future PlansSupport the show

Manifest Change with Brooklyn Storme
Reschedules in Private Practice | Why They Happen | What You Can Do

Manifest Change with Brooklyn Storme

Play Episode Listen Later Mar 24, 2025 44:24


Apply for Practice Momentum before 15th April 2025 and secure your Founding Client thank-you fee!    In this episode, we talk about all things Rescheduling. If you've noticed an increase in reschedules, you're not alone - it's happening to other people in private practice too across disciplines including psychologists, social workers, counsellors and play therapists. In this episode, you'll learn what's behind / what's causing the reschedules, what it means for your business and what it means for your clients. You'll leave with ideas on what to focus on in the practice to support your clients and minimise lost cash flow.   

Policy Outsider
Ep. 102. Re: Rescheduling

Policy Outsider

Play Episode Listen Later Feb 27, 2025 17:16


With a new presidential administration come new (and dimmer) prospects for the rescheduling of cannabis. The rescheduling process, which began under President Biden, has met with legal hurdles and will now be overseen by a group of Trump appointees that view the drug less favorably. On a new episode of Policy Outsider, Rockefeller Institute director of operations, fellow, and resident cannabis policy expert, Heather Trela, provides an update on where we are in the process, the new players, and what to expect in the coming months.

Kaya Cast
The Politics of Cannabis: Robert Hoban on Power, Policy, and Progress

Kaya Cast

Play Episode Listen Later Feb 25, 2025 33:03


In this enlightening episode of the Kaya Cast Podcast, we sit down with cannabis industry pioneer, Robert Hoban, a seasoned legal expert and consultant known affectionately as the "CanSigliere." With a career stretching over nearly two decades, Bob has been at the forefront of cannabis policy and law, helping shape the framework that supports today's burgeoning market. He has transitioned from practicing law to advising international governments on cannabis policy and working as a fractional executive in global cannabis supply chains.During our conversation, Bob shares insights into the evolution of cannabis regulations, the complexities of the hemp and marijuana industries, and his current roles which include teaching at UNLV's new Cannabis Policy Institute. We also delve into the future of cannabis laws, particularly focusing on what to expect as we approach 2025 and beyond in regulatory changes across the United States and internationally. Bob discusses the challenges and opportunities faced by the industry, touching on state vs federal regulations, the impact of upcoming administrations on cannabis policy, and how different sectors such as pharmaceuticals, dispensaries, and hemp derivatives will be influenced by new laws. His unique perspectives on how we can navigate and influence future policies provide a compelling narrative not just for those directly involved in the cannabis industry but also for anyone interested in the intersection of entrepreneurship, law, and cannabis reform.Don't miss this comprehensive dialogue on the currents and undercurrents shaping the cannabis industry with one of its most influential voices.Find out more about Robert here:www.bobhoban.comhttps://www.linkedin.com/in/rhoban/https://www.gps.global/Highlights:00:00 Introduction and Greetings00:08 Bob's Background in Cannabis Law01:30 Cannabis Policy and Regulation03:32 Future of Cannabis Industry08:31 Hemp Derivatives and Federal Regulations17:39 Consumer Behavior and Market Trends19:13 Public Dialogue and Industry Unity21:02 Starting a Business in the Cannabis Industry21:27 Cannabinoid Producers Leading the Market22:08 Global Cannabis Supply Chain23:30 Morocco's Cannabis Industry24:57 Challenges and Opportunities in Morocco27:32 Hemp vs. Marijuana Industry Dynamics29:15 Adapting to Market Changes31:10 State-Level Cannabis Legislation33:27 Federal Cannabis Policy and Future Outlook36:32 Optimism for the Future40:45 Conclusion and Final Thoughts#kayacast

Khaled Nassra Method - Learn Arabic On The Go
#348 Must-Know Levantine Arabic Phrases for Booking, Rescheduling & Canceling

Khaled Nassra Method - Learn Arabic On The Go

Play Episode Listen Later Feb 18, 2025 6:21


The Cannabis Accounting Podcast by DOPE CFO
Ep. 162: A Deep Dive Into the Rescheduling Chaos with NCIA's Aaron Smith

The Cannabis Accounting Podcast by DOPE CFO

Play Episode Listen Later Feb 10, 2025 41:55


The Cannabis industry stands at a pivotal moment as multiple reform paths converge. From state-level progress to federal rescheduling efforts, understanding the complex landscape is crucial for industry professionals. Recent developments in the DEA rescheduling hearings have created both uncertainty and opportunity, making it essential to stay informed and engaged.Join DOPE CFO's Andrew Hunzicker and NCIA CEO Aaron Smith as they break down:Latest updates on the DEA rescheduling hearing cancellation and its implicationsHow recent administrative changes could impact Cannabis reform effortsMultiple pathways to federal reform and their current statusStrategic opportunities for industry engagement in reform effortsRole of industry professionals in advancing positive changeCritical insights into state-level developments and federal policy interactionsWhether you're a Cannabis accountant, operator, or industry advisor, this episode provides essential context for understanding current reform efforts and opportunities for engagement. Learn how recent developments affect your business and how to participate in shaping the industry's future.

Cannabis Legalization News
DEA Rescheduling and Cannabis Industry Updates | Cannabis Legalization News

Cannabis Legalization News

Play Episode Listen Later Jan 19, 2025 65:02


Send us a textIn this episode of Cannabis Legalization News, we cover the latest news in cannabis legalization, including the DEA's rescheduling efforts, Donald Trump's upcoming presidency, and Judge Mulrooney's involvement in the rescheduling matter. We also discuss the interplay between state and federal laws, the economic impact of cannabis legislation, and noteworthy stories about DEA imposters and viral TikTok incidents. Key themes include cannabis taxes, administrative law, regulatory challenges, and the ongoing evolution of cannabis laws in the United States.00:00 Introduction and Member Shoutout00:37 DEA Rescheduling and Legal Ramifications01:39 Interlocutory Appeal Explained02:32 Footnotes and Legal Documents03:42 Cannabis Industry Challenges14:45 TikTok, Influencers, and Cannabis32:15 The Future of AI Research32:37 Name That Strain: Cheese Edition35:29 Biden's Clemency and Cannabis Reform38:05 Cannabis Industry Lobbying and Mergers44:22 48:18 State-Level Cannabis Legislation UpdatesSupport the show

Cannabis Legalization News
Cannabis Legalization: Hemp vs Marijuana Wars & Federal Rescheduling

Cannabis Legalization News

Play Episode Listen Later Jan 12, 2025 63:26


Send us a textIn this episode, Tom dives into the latest cannabis legalization news, leading with an innovative hemp app that's making headlines. The crew covers significant updates from Texas' legislature, a landmark case from Virginia, and new developments in Illinois. They also discuss the intriguing news about alcohol regulation and its potential impact on the upcoming farm bill. Rhode Island is on the radar with its new cannabis licensing rules, and Ohio's DEA news adds more to the discussion. The conversation transitions to reflections on the six-year journey of the podcast, audience engagement, and a thought-provoking quiz about THC in hemp products. The discussion heats up with DoorDash's entry into the cannabis delivery market and its implications. Finally, they cover crucial legal battles around cannabis and hemp regulations, touching on significant court rulings from Florida and Virginia, and the ongoing legislative struggles in Illinois and Virginia.00:00 Introduction and Lead Story01:12 Trending Stories and Co-Hosts02:47 Hemp vs Marijuana Debate02:59 DoorDash and Hemp Beverages04:23 Synthetic Cannabinoids and Legal Issues06:40 Alcohol Warnings and Cannabis09:03 Workplace Cannabis Use Study18:00 AI in Law and Legalization27:08 Virginia's THC Regulation31:25 Tomato Talk and Cannabis References31:58 Name That Strain: Purple Monkey Balls35:57 Illinois Cannabis Legislation and Lobbying43:44 Ohio's Recreational Cannabis Success55:19 Virginia's Cannabis Legalization Struggles58:55 Cannabis Studies and Misinformation01:02:07 Conclusion and Future OutlookSupport the show

Irish Breakdown
Rapid Fire: CFP Executive Director Rich Clark Talks Notre Dame Rescheduling, Freeman's Contract Extension, Pat Coogan

Irish Breakdown

Play Episode Listen Later Jan 7, 2025 36:48


Today's Rapid Fire topics include: * Fill-in the blank...Marcus Freeman's extension looks BLANK today. * Sports media reporter John Ourand hosts a sports media podcast called The Varsity. He had College Football Playoff executive director Rich Clark as a guest this weekend and Clark talked about how they came to the decision to have last Thursday's Sugar Bowl kickoff at 4 Eastern/3 Central Time when they had to push it back a day last week. We discuss his explanation. * We hear more from Clark on why the CFP couldn't flip flop the Orange Bowl and Cotton Bowl semifinal games to give Notre Dame an extra day of preparation after their game was delayed by a day last week. * We hear Irish defensive coordinator Al Golden's thoughts on defensive tackle Gabe Rubio and discuss Rubio's play vs Georgia after the loss of Rylie Mills. * We hear and discuss Freeman's description of the preparation the Irish did for the 4th and 1 play in the fourth quarter that drew a key offsides call on Georgia. * We hear more from Freeman on offensive lineman Pat Coogan and discuss Coogan's fiery pregame speeches with his teammates. Shop for Irish Breakdown gear at our online store: https://ibstore.irishbreakdown.com/ Join the Irish Breakdown premium message board: https://boards.irishbreakdown.com Stay locked into Irish Breakdown for all the latest news and analysis about Notre Dame: https://www.irishbreakdown.com​ Subscribe to the Irish Breakdown podcast on iTunes: https://podcasts.apple.com/us/podcast/irish-breakdown/id1485286986 Like and follow Irish Breakdown on Facebook: https://www.facebook.com/groups/irishbreakdown Sign up for the FREE Irish Breakdown daily newsletter: https://www.subscribepage.com/irish-breakdown-newsletter

Jake’s Small Market Sports Take
Playoffs, Angry Fans, Rescheduling, Pro Bowl, Jalen's curtain call

Jake’s Small Market Sports Take

Play Episode Listen Later Jan 3, 2025 16:33


We recap the college football playoff second round, why are fans calling for Kalen Deboer after one year, The Sugar Bowl was rescheduled and I think it was the right move, pro bowl rosters are out, and we break down Jalen Milroe's last game

Before Breakfast
Rescheduling without a new date is canceling

Before Breakfast

Play Episode Listen Later Jan 2, 2025 4:54 Transcription Available


Unless it's on the calendar, it isn't happeningSee omnystudio.com/listener for privacy information.

Higher Exchanges
2025 Cannabis Investing Predictions

Higher Exchanges

Play Episode Listen Later Dec 20, 2024 62:37


The boys are back for the final show of the year. This week, they discussed what they got wrong in their 2024 predictions and made fresh predictions for 2025. Topics covered include: - Rescheduling timeline- Boies Schiller Flexner lawsuit- Potential Republican reform- Price compression- Intoxicating hemp- Potential M&A- Dispersion in returns and stock prices- The future of intoxicating hemp, and more...Many thanks to everyone who listened this year, and we look forward to more conversations in the new year!

The CMA Show
EP 169: Rescheduling Your CMA Exam

The CMA Show

Play Episode Listen Later Dec 12, 2024 6:42


In today's episode, I'm discussing when and how to reschedule your CMA exam. We'll explore valid reasons for postponing, the best times to avoid fees, and step-by-step rescheduling procedures. Perfect for those facing unexpected changes or needing more prep time. Tune in to learn how to smoothly navigate this process! ---------- RESOURCES & LINKS MENTIONED IN THIS EPISODE:

Cannabis Legalization News
DEA Rescheduling Deep Dive: Allegations, Lawsuits, and What's Next for Federal Cannabis Policy

Cannabis Legalization News

Play Episode Listen Later Dec 1, 2024 63:36


Send us a textIn this episode of Cannabis Legalization News, the hosts dive into the DEA's complex rescheduling process, discuss the latest news on cannabis licenses in Minnesota, Kentucky, and Florida, and examine the impact of recent farm bill drafts on hemp regulations. They also provide updates on the medical marijuana landscape in Nebraska and share plans for the upcoming MJBizCon event in Las Vegas. Join the discussion on procedural issues facing the DEA, the nuances of state-specific cannabis regulations, and the broader implications for cannabis legalization efforts nationwide.00:00 Introduction and Today's Agenda00:20 Upcoming DEA Hearing Details01:10 Member Interactions and Roomba Talk01:41 Deep Dive into DEA Rescheduling02:47 Procedural Issues and Legal Challenges08:14 Hemp Loophole and Legalization Challenges18:41 FOIA Requests and Transparency28:24 Court Rulings and Voter Fraud Allegations28:38 Nebraska's Hemp Loophole and Medical Weed Battle29:14 Legal Challenges and Ignorance in Cannabis Legislation34:14 Minnesota's Lottery and Legal Disqualifications41:56 Kentucky's Cannabis Licensing and Social Equity56:22 Federal Farm Bill and Hemp Regulations58:57 Florida's New MMTC Licenses and State Comparisons01:02:28 Concluding Thoughts and Upcoming EventsSupport the show

BREAK/FIX the Gran Touring Motorsports Podcast
The First Horseless Carriage Race (David Schmidt)

BREAK/FIX the Gran Touring Motorsports Podcast

Play Episode Listen Later Nov 28, 2024 30:07 Transcription Available


The 1895 Horseless Carriage Contest sponsored by the Chicago Times-Herald (aka "first" auto-race in America) - a peek into the WHAT, WHY. WHEN. WHERE, WHO beyond the auto history lore of a Duryea victory on a cold and snowy, Thanksgiving Day in Chicago. David Schmidt is a Director at the Society of Automotive Historians (SAH) as well as Panel Chair for the SAH Bradley Award. He is also a member of the Porsche Club of America and Fuelfed, a private club for enthusiasts of European cars. Born in Detroit, his father and grandfather both worked for GM at Fisher Body. Being a product of a certain generation he experienced the muscle car era first hand cruising the famed Woodward Avenue in the late 1960's. David received a BA from Michigan State University, MA and PhD from Indiana University and after a career in financial services retired from TIAA. As an auto enthusiast, he can be seen driving about town in a 1967 Volvo Amazon or 1989 Porsche Carrera. The importance of this event is perhaps best captured that same year by Peter Studebaker of the eponymous wagon maker who, with prescience, commended the sponsoring newspaper “... for transferring the manufacture of the motocycle (a term applied to the horseless carriage after a naming contest) concentrating the inventive faculties of the nation on this [horseless carriage] new departure.” ===== (Oo---x---oO) ===== 00:00 Introduction and Sponsors 00:16 The 1895 Horseless Carriage Contest Overview 00:37 Presenter Background: David Schmidt 01:21 Significance of the 1895 Race 02:53 Race Day Preparations and Challenges 07:10 The Thanksgiving Day Race 08:44 Post-Race Analysis and Awards 10:07 Impact and Legacy of the 1895 Race 10:43 Why the 1895 Race Was Held 11:29 The Role of the Chicago Times Herald 14:56 Rescheduling and Final Preparations 16:08 The Birth of American Auto Racing 16:28 Why Chicago? 18:18 The Bicycle Craze and Its Influence 19:44 Chicago: The Transportation Hub 20:30 Unsung Heroes of the Horseless Carriage 21:18 The Tragic Tale of Hieronymus Muller 22:06 Charles B. King: A Prodigious Inventor 23:36 The Electrobat: An Electric Pioneer 24:56 The Battle of Electric vs. Gasoline 26:23 Steinway's Automotive Adventure 27:34 Conclusion and Acknowledgements ==================== The Motoring Podcast Network : Years of racing, wrenching and Motorsports experience brings together a top notch collection of knowledge, stories and information. #everyonehasastory #gtmbreakfix - motoringpodcast.net More Information: https://www.motoringpodcast.net/ Become a VIP at: https://www.patreon.com/ Online Magazine: https://www.gtmotorsports.org/ This episode is part of our HISTORY OF MOTORSPORTS SERIES and is sponsored in part by: The International Motor Racing Research Center (IMRRC), The Society of Automotive Historians (SAH), The Watkins Glen Area Chamber of Commerce, and the Argetsinger Family - and was recorded in front of a live studio audience.

Cannabis Man
Cannabis in Transition: Green Rose CEO Ross Morreale, Rescheduling Optimism, and High Haiku Debut

Cannabis Man

Play Episode Listen Later Nov 15, 2024 78:39


Text Cannabis Man!In this episode, host Don Kleppin dives into the origins of the show and its mission to reshape the cannabis conversation. In the News Joint Wrap, he breaks down Illinois lawmakers' ongoing battle over hemp product bans and upcoming tax rate changes in 2025.The product review of the week highlights Sweetbuzz's delicious Cookie Got Creamed cups, offering a detailed look at these creative cannabis treats.Don's guest is Ross Morreale, CEO of Green Rose Dispensaries, who shares his insights on Illinois' cannabis industry, transitioning from a multi-state operator to a focus on social equity.The episode's headline news is the nomination of Florida Congressman Matt Gaetz as U.S. Attorney General, hailed as one of the most pro-cannabis Republicans on Capitol Hill. Don unearths audio of Gaetz pressing the DEA on cannabis rescheduling, and breaks down how this nomination could fast-track long-awaited reform.Also covered: a federal lawsuit challenging the DEA's rescheduling hearings, highlighting concerns over agency bias and conflicts of interest.Finally, Don wraps up with the debut of the High Haiku, a whimsical cannabis-inspired poetry segment, and invites listeners to rate, review, and subscribe to the show and The Weekly Chronic newsletter.Support the showThanks for listening!Follow the show on Facebook, YouTube, Twitter and Instagram!Get points at dispos with High Rewards! Use Promo Code: CannManInterested in advertising? Email host@cannabismanpodcast.com!Thinking of starting a podcast? Host with Buzzsprout!

We Get Work
Navigating Cannabis Rescheduling: Key Insights for Healthcare

We Get Work

Play Episode Listen Later Nov 7, 2024 27:38


Earlier this year, the DEA responded to President Biden's directive to reschedule cannabis from Schedule I to Schedule III of the Controlled Substances Act. This pivotal change, if finalized, would reclassify marijuana as a drug with moderate to low potential for dependence, strictly for medical use.  Chapters 00:00 Introduction to Workplace Issues and Cannabis Rescheduling 05:06 Understanding the Rescheduling Process of Cannabis 09:48 Implications of Rescheduling for Employers 15:07 Legal Challenges and Considerations for Healthcare Employers 19:50 Navigating Drug Testing and Employee Policies 24:51 Conclusion and Future Considerations

Cannabis Man
DEA Delays Rescheduling, Best in Grass Awards & Cannabis Education with Alpine IQ's West Paschal

Cannabis Man

Play Episode Listen Later Nov 1, 2024 79:12


Text Cannabis Man! In this Halloween-themed episode, Don sets the tone by reflecting on the perfectly spooky fall atmosphere in Chicago, where high winds and gray skies make the season's colors pop. He shares highlights from the latest hemp industry updates in the News Joint Wrap and takes listeners through a full breakdown of the Best in Grass Illinois Awards, celebrating this year's winners and recounting connections made at the event. Don also shares a meaningful moment with a listener who thanked him for the show's impact on their family. The episode's main feature is an in-depth interview with West Paschal of Alpine IQ, exploring how cannabis businesses can better connect with their customers and educate the public as legalization spreads. Don and West discuss the challenges cannabis businesses face, the importance of consumer education, and the current legal climate. Lastly, Don covers breaking news that the DEA's long-awaited administrative hearing on cannabis rescheduling, initially set for December 2, has been unexpectedly delayed to early 2025, leaving the industry in suspense for just a bit longer. Support the showThanks for listening!Follow the show on Facebook, YouTube, Twitter and Instagram!Get points at dispos with High Rewards! Use Promo Code: CannManInterested in advertising? Email host@cannabismanpodcast.com!Thinking of starting a podcast? Host with Buzzsprout!

Cannabis Man
NORML's Paul Armentano on Rescheduling & the Future of Legalization

Cannabis Man

Play Episode Listen Later Oct 25, 2024 90:55


Text Cannabis Man!In this milestone episode of the Cannabis Man Podcast, host Don Kleppin celebrates the show's incredible reach across all 50 states and 85 countries, along with its recognition as the #1 indie news podcast on GoodPods. Don reflects on the global progress of cannabis legalization and shares the latest Illinois sales figures, upcoming Best In Grass Awards, and product reviews, including SweetBuzz's Sweet Sparks and Tales & Travels' Grandi Guava flower.This week's guest is Paul Armentano, Deputy Director of NORML, who joins Don to discuss the DEA's rescheduling timeline, the latest FBI cannabis arrest numbers, Florida's legalization ballot initiative, and more. Don also covers national cannabis news, including a Florida prosecutor's stance on Amendment 3 and Republican VP nominee JD Vance's remarks on fentanyl-laced cannabis. Plus, hear a fun story about Snoop Dogg's personal "chaperone."To start earning points on cannabis purchases download the High Rewards app and use the promo code CANNMAN for 5$! Rate and review the show, and share thoughts via text on cannabis products and topics. Subscribe to the Weekly Chronic newsletter for more!Support the showThanks for listening!Follow the show on Facebook, YouTube, Twitter and Instagram!Get points at dispos with High Rewards! Use Promo Code: CannManInterested in advertising? Email host@cannabismanpodcast.com!Thinking of starting a podcast? Host with Buzzsprout!

Cannabis Investing Network
#202 - Trade or Hold Cannabis Stocks into the Election? (ft. Charting Man Dan of The Chart Guys)

Cannabis Investing Network

Play Episode Listen Later Sep 18, 2024 57:29


In this episode we are joined by Dan from The Chart Guys to discuss cannabis investing vs strategies heading into the November election. We compare game plans and discuss how Dan thinks about Florida Rec, Rescheduling and potential campaign discussions about cannabis. Big thanks to Dan for joining us for another great discussion. Follow Dan / The Chart Guys On Twitter: ⁠⁠⁠https://twitter.com/ChartGuys⁠⁠⁠ The Chart Guys on Youtube: ⁠⁠⁠https://www.youtube.com/channel/UCnqZ2hx679DqRi6khRUNw2g⁠⁠⁠ Free Intro to TA course: ⁠⁠⁠https://www.chartguys.com/trading-courses/7/technical-analysis⁠⁠

Land Line Now
Land Line Now, Sept. 5, 2024

Land Line Now

Play Episode Listen Later Sep 5, 2024 51:04


The government is pushing for electric trucks. But the difficulties caused when those trucks' batteries catch fire have caught the Department of Transportation's attention. Also, for many owner-operators, finding a load that pays well enough is half the battle – and requires spending some time on load boards. We'll explain how to find a good one. Then, OOIDA and Truckers Against Trafficking have joined for a special giveaway to celebrate National Truck Driver Appreciation Week. 0:00 – Newscast  10:07 – Electric truck fires draw attention of U.S. DOT 25:00 – How do you find a good load board? 40:06 – TAT, OOIDA join to honor truck drivers

The Ricochet Audio Network Superfeed
The Federalist Society's Teleforum: The Law, Policy, and Politics of Rescheduling Cannabis

The Ricochet Audio Network Superfeed

Play Episode Listen Later Jul 24, 2024


The legal status of cannabis has been a controversial issue ever since the Controlled Substances Act of 1970 (CSA) prohibited its distribution under federal law. That act classified cannabis as a Schedule I drug, a category for drugs that have no legitimate medical use and cannot be used safely even under medical supervision. Schedules II-V […]

Opening Arguments
Cannabis Rescheduling; Judge Cannon Stops Trump Trial

Opening Arguments

Play Episode Listen Later May 10, 2024 75:36


OA1031 First up, BIG ANNOUNCEMENTS!!! The Trump Trial Transcript readings will now only be available on patreon.com/gavelpod! Details inside. Then: the Biden administration is moving forward with rescheduling marijuana to a lower federal classification--and Matt is not happy about it? Find out why this long-overdue acknowledgment of the over-criminalization of cannabis may not only be too little too late, but actually the wrong direction for criminal and social justice. And speaking of justice gone wrong: Aileen Cannon. Fort Pierce, Florida's best (and only) federal trial judge has once again put off Trump's classified documents case, this time with no end in sight. We take a closer look at what she is actually doing here before checking in on Trump's latest success in delaying his RICO trial for election interference in Georgia. We finish up with Thomas Takes the Bar Exam, in which Thomas  find out how he did in the strange case of the arsonist who doesn't understand how fire works before wagering his eternal soul on a new question about a sick violinist. Formal HHS recommendation that cannabis be moved to Schedule III (8/29/23) “Legalize it All,” Dan Baum, Harper's (April 2016)(source of 1994 John Ehrlichman quote as personally recorded by the author) Gonzales v. Raich, 545 U.S. 1 (2005) The Cannabis Administration and Opportunity Act (2022 Senate bill removing marijuana from federal drug schedules and putting it under FDA regulation reintroduced by Chuck Schumer on 5/1/2024) Judge Cannon's Order Setting Second Set of Pretrial Deadlines/Hearings (5/7/24) If you'd like to support the show (and lose the ads!), please pledge at patreon.com/law!